{
    "paper_id": "0b04837dd174611a78811f37654ba1ef04aa01b0",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Adaptive immune responses 1: 476, 1:509e510, 3:179e180, 4:222e223, 4:335e336, 4:345 to fungal infection 4:79e80 B lymphocytes in fungal infection 4:79 important role of DCs in molding the T cell response 4:79 T cell responses to fungal pathogens 4:80 IFN effects on 4:226 immunoglobulin 1:510 T cell 3:384 T cell receptors 1:509e510 without viral clearance 4:226e227 Adaptive immune system (AIS) 1:541e543, 3:344 ab T cells 1:542 antibodies 1:541e542 B cells 1:542 of birds 1:500e502 development of 5:113e116 evolution of 1:468, 1:472 gd T cells 1:542e543 in lagomorphs 1:516e518",
            "cite_spans": [
                {
                    "start": 29,
                    "end": 83,
                    "text": "476, 1:509e510, 3:179e180, 4:222e223, 4:335e336, 4:345",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "comparisons of European rabbit with other lagomorphs 1:517e518 comparisons of European rabbit with other mammalian models and chicken 1:516e517 contributions to basic immunology from studies in European rabbit 1:516 precursors of 1:410 T cells 1:542 Adaptive immunity 1:535e536, 2:220, 2:427e428, 2:494, 4:136e138, 4:408f, 5:40e41, 5:378, 5:385e386 in asthma 5:297e299 Th2 response 5:298 Th17 response 5:299 B cells 5:41 in brain 5:58e60 antigen presentation in CNS 5:58 B cells 5:59 cytotoxic T cells 5:58 helper T cells 5:58e59 lymphocyte migration and control 5:59e60 regulatory T cells 5:59 and innate immunity distinction between 2:455 mediation of cross talk between 2:461 in jawless vertebrates 2:148e152 lymphocytes 1:535 mast cell involvement in 1:316 natural killer (NK) cells 5:41 natural killer T (NKT) cells 5:41 T cell receptor (TCR) gd 3:325 T cells 5:40e41 tripartite 3:325 Adaptive lymphoid cells, polarization of 2:443e444 Adaptive T lymphocytes and B lymphocytes 5:15 Adaptor protein (AP-3) 2:257e258 Addison's disease 5:439",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Adenoids as nose-associated lymphoid tissue 3:424e425 Adenosine deaminase (ADA) deficiency 5:518 Adenosine triphosphate (ATP) 4:412, 5:252 -dependent chromatin-remodeling complexes 1:31 Adenoviruses 4:319e320, 4:561 Adhesion and degranulation-promoting adapter protein (ADAP) 3:10 Adhesion molecules 1:137, 1:339 involved in leukocyteeendothelial interactions 3:513f leukocyte 3:67e69 See also Blood vascular endothelial adhesion molecules Adhesion strengthening 3:74e75 Adipocytes 5:275e276 Adipose tissue 5:37e45 adaptive immunity 5:40e41 B cells 5:41 natural killer (NK) cells 5:41 Natural Killer T (NKT) cells 5:41 T cells 5:40e41 brown and beige adipose tissues, immunology of 5:41e42 inflammation during obesity 5:38f, 5:39e40 innate immune cells 5:38e40 eosinophils and ILC2s 5:39 macrophages 5:38e39 mast cells 5:40 neutrophils 5:39e40 -resident immune cells 5:38, 5:42e43 white adipose tissue (WAT), immunology of 5:37e38",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "human African trypanosomiasis (HAT) 4:104 innate human resistance 4:102 to study protective antitrypanosome responses 4:102e104 chronic phase of infection 4:104 control of parasitemia peak and adaptive immunity 4:104 early innate phase 4:103e104 vaccination 4:104e105 Agammaglobulinemia 5:459, 5:513, 5:517 clinical consequences of 5:463e464 gene defects leading to 5:461t peculiar cases of 5:463 Age-related macular degeneration (AMD) 5:27e28, 5:506 Aggressors 1:410e413 defense against animal predators 1:412e413 defense against microbial pathogens 1:410e412 bacteria 1:411e412 fungi 1:412 virus 1:412 Aging acquired immunity in 5:127e130 and bacterial infections 3:216e217 gender and immunosenescence 5:130 immunity and 5:127e132 inflammaging 5:130e131 innate immunity in 5:127 Agnathan immune response 1:468e474, 2:151",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "adaptive immune system (AIS), evolution of 1:472 antigen receptors 1:468e470 effector functions 1:471e472 of VLRA + cells and VLRC + cells 1:471e472 of VLRB + cells 1:471 lymphocyte 1:470 development 1:470 subsets 1:470 Agonist selection 1:242, 1:277e278, 1:277f Aicardi-Gouti\u00e8res syndrome (AGS) 2:356e357, 5:145, 5:500 AICDA 2:116e117 Aiptasia 1:404 Aiptasia pallida 1:402e403 Airborne childhood infections and vaccination 5:330 Airway epithelium, activation of 5:297 Airway hyperresponsiveness (AHR) 5:295, 5:298e300, 5:323 Airway immune system 3:453e465 animal models 3:454 immune cells 3:460e462 compensatory lung growth after major resection 3:461 effect of nanotubes and ultrafine particles on the lung immune system 3:462 emigration of immune cells from bronchoalveolar space 3:460 immune functions of pleural space 3:461 immunosenescence 3:461 increase in number of DCs in sensory ganglia 3:462 in larynx 3:461e462 in lung, number, subsets, and compartments 3:454 lymphocyte migration 3:460 microbiology of the lung 3:462 pulmonary vascular pool of lymphocytes 3:461 organized lymphoid tissue in the respiratory tract 3:459e460 bronchus-associated lymphoid tissue (BALT) 3:460 larynx-associated lymphoid tissue (LALT) 3:460 nose-associated lymphoid tissue (NALT) 3:459e460 respiratory tract air-conducting parts of 3:457e458 allergic sensitization process, influence of lipid on 3:458 alveolus cells 3:457 B lymphocyte lineage cells in the respiratory system 3:459 bronchiolar dome cells 3:458 brush cells 3:458 chemosensory cells 3:458 clinical relevance of immune reactions in 3:453e454 critical role of stereology 3:456 embryology of lung 3:455e456 epithelial barrier in asthma 3:459 intraepithelial DCs in conducting airways 3:456e457 lipid bodyecontaining interstitial cells 3:458 nerves in 3:459 pulmonary cells with great species differences and partly unknown functions 3:458 pulmonary DCs 3:457 quantification of effects of diseases 3:456 relevance for immune reactions in the nose 3:458e459 role of airway epithelium in allergic sensitization 3:458 sessile alveolar macrophages 3:458 structure and cells of 3:455e459 tracheobronchial epithelium, development and differentiation of 3:456 treatment of the lung 3:456 wall of 3:454e455 surfactant A in bacterial clearance 3:462 Airway microbiome 5:338 Airway remodeling 5:300 of airway smooth muscle 5:300 deposition of ECM proteins 5:300 mucous metaplasia 5:300 thickening of basement membrane 5:300 Airway smooth muscle (ASM) 5:299 remodeling of 5:300 Akt 1:58e59 Albumin 5:283",
            "cite_spans": [
                {
                    "start": 1219,
                    "end": 1225,
                    "text": "(LALT)",
                    "ref_id": null
                },
                {
                    "start": 1264,
                    "end": 1270,
                    "text": "(NALT)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Alemtuzumab (anti-CD52) 4:550e551, 4:551t, 5:259, 5:266e267, 5:516e517 Alendronate, and TCRgd activation 2:79 Alkyl bisphosphonates, and TCRgd activation 2:79e80 Alkylamines, and TCRgd receptors 2:79e80 Allele Frequency Net Database (AFND) 1:373 Allelic exclusion 1:107, 2:58",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Igh recombination 1:66e67 Igk locus 1:74e75 in TRB gene regulation 2:88e89 Allergen immunotherapy (AIT) 5:313e320 allergen preparations 5:314e315 allergoids 5:314 combination of allergens with innate immune activators 5:315 peptides 5:315 recombinant allergens 5:314 basophils and mast cells, early desensitization of 5:315 clinical efficacy of 5:313e314 atopic dermatitis 5:314 food allergy 5:314 hymenoptera venom allergies 5:313e314 respiratory allergies 5:313 effector and regulatory lymphocyte subsets, changes in 5:315e317 historical background 5:313 humoral response, changes in 5:317 immune responses regulation by 5:315 healthy and allergic immune responses to allergens 5:315 mechanisms of allergen immunotherapy 5:315 reduced skin reactivity and tissue effector cells 5:317 Allergens 2:522e523, 4:166e167, 4:167f, 4:169e171, 5:281e289, 5:337t",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "avoidance 5:325 for diagnosis and immunotherapy 5:286e287 healthy and allergic immune responses 5:315 inhalant allergens 5:282e285 food allergens 5:284e285 indoor allergens 5:282e283 outdoor allergens 5:283e284 structure and implications for allergenicity 5:285e286 Allergen-specific IgE 4:169 Allergic airway inflammation 2:435 ILC2s in 1:383 Allergic asthma 1:384e385, 5:329, 5:337t, 5:338 biologicals to treat 5:321e327 current standard and future biologicals 5:325e326 immune pathways in 5:296f Allergic contact dermatitis (ACD) 5:290e294",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "allergen exposure by skin penetration, hapten formation, and protein binding 5:291",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Allergic contact dermatitis (ACD) (continued) elicitation by direct activation of T memory cells 5:293 innate lymphoid cells (ILCs) 5:293 keratinocytes, mast cells, and neutrophils 5:292e293 sensitization 5:291e292 Allergic diseases 5:337t mast cells in 1:316e317 TGFb in 2:567 Allergic immune system 5:321 Allergic inflammation 1:326 Allergic march 5:337 Allergic rhinitis 5: 325, 5:337, 5:337t, 5:437e438 associations between CRSwNP and 5:310 epidemiology 5:306 mechanisms of 5:307e308 early-phase response 5:307 late-phase response 5:307e308 sensitization 5:307 treatment 5:306 Allergoids 5:314 Allergy 2:220, 2:566, 5:347 environmental factors influencing 5:338e339 epidemiology of 5:336e337 evidence for microbial-mediated modulation of 5:338e339 microbiome and 5:336e345 prevention prebiotics/fermentable fibers 5:342 probiotics 5:342 prevention of 4:168e169 Alligator mississippiensis 1:494 Alloantibody 5:255e256 Allogeneic hematopoietic stem cell transplantation (allo-HSCT) 1:362, 4:422, 5:448, 5:489e491 Allograft 1:296 adaptive alloimmune responses 5:254e256 alloantibody 5:255e256 allorecognition pathways 5:254 B cells 5:254e255 T cells 5:254 corneal, immune privilege of 5:26e27 innate response 5:250e254 complement 5:250e252 innate lymphoid cells (ILCs) 5:253e254 phagocytes 5:252e253 Allograft inflammatory factor 1 (AIF-1) 1:410 Allopurinol hypersensitivity, and HLA 2:314e315 Allorecognition and highly variable immune response gene repertoires 1:427 Allorecognition pathways 5:254 Alloresponse 1:361e365 Allotransplantation 5:270 All-trans retinoic acid (ATRA) 1:296, 4:519te520t a4b1 integrin 3:508",
            "cite_spans": [
                {
                    "start": 377,
                    "end": 406,
                    "text": "325, 5:337, 5:337t, 5:437e438",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "See also Very late antigene4 (VLAe4) a4b7 integrin 3:509, 5:5e6 ab T cell receptors 1:234e236 ab T cells 1: 505, 1:542, 5:198e199 lineage specification, influence of g c on 1:195e196 CD4 versus CD8 lineage choice 1:195 thymus-derived regulatory CD4 + T cells 1:195e196 a-defensins 1:285 a-glycosphingolipids (aGSLs) 2:258 a-helical cytokine receptors, structural features of 3:125e127 a-helical cytokines 3:125f a-hemolysin 2:432 a-human neutrophil peptide (HNP) 5:65 aLb2 integrin 3:508",
            "cite_spans": [
                {
                    "start": 108,
                    "end": 129,
                    "text": "505, 1:542, 5:198e199",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "See also Leukocyte functioneassociated antigene1 (LFAe1) aMb2 integrin. See Leukocyte-expressed Mac-1 a-thrombin 2:340 a-fetoprotein 4:421 a-smooth muscle actin (aSMA) 3:476 avirus 4:332e333, 4:335 Altered repertoire model 2:313e314 chronic beryllium disease 2:314 Alternaria 5:284 Alternative activation 2:521 Alternative end-joining (A-EJ) 2:107, 2:140 Alternative pathway (AP) of complement 2:325e331 activation 2:326e327 atypical hemolytic uremic syndrome 2:329 deficiencies predispose to microbial infections 2:328e329 dense deposit disease 2:329 disturbances in 2:328e330 factors H and I 2:327 membrane regulators 2:327e328 paroxysmal nocturnal hemoglobinuria (PNH) 2:330 regulation of 2:327e328 components 2:325e326 functions of 2:327t recognition 2:326f Alternative splicing 2:31 Alternatively activated macrophages (AAMs) Anthopleura elegantissima 1:402e403 Anthozoa 1:397e398 Anthrax 1:521 Antibacterial immunity 1:331 Antibacterial peptidoglycan recognition proteins 2:394 Antibodies (Abs) 1:541e542, 3:157, 3:216, 4:280 activity of polyclonal Ab suspensions 4:281 acute antibody-mediated rejection 5:256e257, 5:269 aggregation of virion particles, and 4:283 alloantibody 5:255e256 anticitrullinated protein antibodies 5:212 antiendomysial 5:222e223 antigenic recognition capacity of 4:282 antinuclear antibody testing 5:488 antisperm 5:51 antitumor antibody responses, Th cells and 4:444 autoantibodies 3: 240e241, 4:429e431, 5:168e170, 5:172, 5:204, 5:207, 5:212e213, 5 :446e447 autoimmune orchitis and antisperm antibodies 5:51 B-1 cells 3:240e241 natural antibody secretion 3:238e240 binding antibodies 4:345 blocking the attachment of viruses to surface receptors, and 4:283 broadly neutralizing antibodies 4:346e347 in camelids 2:153e154 heavy chain-only antibodies 2:154e155 for cancer 4:550e556 approved antibodies 4:550e552 clinical trials 4:552e553 identification and molecular engineering of therapeutic antibodies 4:554e555 Ig-like scaffolds 4:555e556 preclinical evidence 4:554 CD25 5:259 celiac disease 5:222e223 chemically programmed antibodies 4:555e556 chemically programmed antibodies (cpAbs) 4:555e556 chicken 1:129 class switching 4:281 class-switching, modulation of 5:340 complement system 4:283 deficiencies 4:376, 5:468, 5:474e475 management of 5:517e518 PLCy2-associated 5:471 development and production in teleosts 1:484e485 dextran-conjugated anti-IgD antibodies 3:229e230 disease-specific antibodies 5:447 Ig-like scaffolds 4:555e556 preclinical evidence 4:554 tetravalent tandem antibodies 4:556e557 therapeutic, identification and genetic engineering of 4:556e557 therapeutic monoclonal antibodies 4:570 thymus independent (TI) antibody response 3:208e212, 3:229e232 tonsillar antibody-producing B cells 3:424 transcytosis 4:282 Antibody-dependent cellemediated",
            "cite_spans": [
                {
                    "start": 1418,
                    "end": 1482,
                    "text": "240e241, 4:429e431, 5:168e170, 5:172, 5:204, 5:207, 5:212e213, 5",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "[cellular] cytotoxicity (ADCC) 1:354e355, 1:355f, 1: 369e370, 2:19e20, 2:321, 2:420, 4:146, 4:263, 4:284f, 4:345, 4:347f, 4:348, 4:444, 4:488e489, 4:496, 4:516, 4 :554e555 Antibody-dependent cellemediated phagocytosis (ADCP) 4:345 Antibody-incompatible transplantation 5:252, 5:259 Antibody-mediated activation 1:329 Antibody-mediated rejection (ABMR) 5: 249, 5:252, 5:257, 5:268 acute 5:256e257 Antibody-producing plasma cells 4:470e475 Antibody-secreting cells (ASCs) 1:95e96, 4:336e337",
            "cite_spans": [
                {
                    "start": 53,
                    "end": 162,
                    "text": "369e370, 2:19e20, 2:321, 2:420, 4:146, 4:263, 4:284f, 4:345, 4:347f, 4:348, 4:444, 4:488e489, 4:496, 4:516, 4",
                    "ref_id": null
                },
                {
                    "start": 355,
                    "end": 379,
                    "text": "249, 5:252, 5:257, 5:268",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Bcell differentiation into 3:208 Anti-CD20 antibody 5:186 Anticitrullinated protein antibodies (ACPAs) 5:212 Anti-CPS4 IgA response 2:28 Anti-CSF-1R mAb treatment 2:587 Anti-CTLA-4-blocking antibody 4:438e439 Antiendomysial antibodies 5:222e223 Antifungal defense, role of pattern recognition receptors (PRRs) in 4:77e79",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "role of C-type lectin receptors (CLRs) in antifungal immunity 4:78e79 role of NOD-like receptors and the inflammasome in antifungal immunity 4:79 role of TLRs in antifungal immunity 4:77e78 Antigen 2:15, 2:17, 2:228, 3:364 -binding cells, activating signals from 3:176 -binding loop architecture, features affecting 2:156e157 crosspresented 2:230e231 -dependent plasma cell 1:110e111 display 3:276e277 immunogenic antigen display 3:276e277 native epitope display 3:276 diversity 4:18e19 drift 4:20e21 -experienced B cells, BAFF and the selection of 1:95e96 BAFF family receptor profiles, change in 1:95e96 for efficient germinal center affinity maturation 1:96 Antigen (continued) mice and humans, similarities and differences between 1:96 therapeutic targets, BAFF and BAFF receptors as 1:96 expressed by virus-induced cancers 4:417 -independent development 1:137e138 -induced arthritis 5:214 loading, MR1 2:267e268 -mediated TCR signaling 3:497 modulation 5:170 peptides, and HLA 2:298e299 presentation 2:249e251, 4:287e289, 4:287f in bony fish 1:482e483 of class I MHC molecules 2:175e176 of class II MHC molecules 2:174 in the CNS 5:58 controlled by tapasin 1:483e484 of HLA-associated diseases 2:299e302 influence of B-1 cells immune system function by 3:240 MR1 2:263, 2:267 and polarization 3:374e375, 3:379e380 by tolerogenic APCs 5:15 processing 2:211e212, 2:243e245 immunodominance 2:245 pH 2:244e245 and PLC 2:236 proteases 2:243 receptor 3:57e58 receptors 1:468e470, 2:102, 3:217f recognition, TCRgd 2:78 regulation of B cell migration and location in response to 3:166e174 -specific immunity 5:6 routes of antigen uptake 5:6 -specific T cells 3:384e385 -specific T lymphocytes 4:570 Teindependent. See Teindependent (TI) antigens transport, in secondary lymphoid organs 3:475, 3:477 variation 4:21, 4:102 Antigen booster vaccine (AIDSVAX gp120 B/ E) 4:349 Antigen processing and presentation machinery (APPM) APPM/HLA-I expression 2:291 biological and clinical impact 2:291 introduction and general concepts 2:280e282 tumor immunoevasion targets 2:286te288t tumor targeting of 2:289e291 viral immunoevasins and their targets 2:283te285t viral targeting of 2:282e289 Antigen recognition, T cell biology and. See",
            "cite_spans": [
                {
                    "start": 661,
                    "end": 680,
                    "text": "Antigen (continued)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Cancer mutanome, personalized immunotherapy targeting Antigen-presenting cells (APCs) 1:251e253, 1:257, 1:268, 1:305, 1:331, 1:487, 1:532, 1:534e535, 2:42e45, 2:44f, 2:200, 2:242e243, 2:248, 2:335, 2:494, 2:526e527, 2:536, 3:1e4, 3:17e18, 3:25, 3:211, 3:287e288, 3:321, 3:327, 3:353, 3:356, 3:374, 3:384, 3:435, 3:466e469, 3:493, 3:497e498, 4:83e84, 4:143, 4:208e209, 4:291e292, 4:441, 4:561e562, 5:13, 5:24e25, 5:31, 5:39e40, 5:55, 5:251e252, 5:379, 5:403e404, 5:474 function 5:195e197 suppression of 5:89e90 of lamina propria 3:430 microglia as 1:305e306 Anti-IgE 2:36, 5:324 Anti-IL-4Ra 5:324e325 Anti-IL-5 5:324 Anti-IL-13 5:325 Anti-IL-17 monoclonal antibody (mAb) 3:291 Anti-inflammatory response (AIR) executioners of 2:549e550 IL-10-mediated 2:547e550 gene specific, AIR as 2:547e548 level of transcription, AIR acting at 2:548 new protein synthesis, AIR requiring 2:548 Socs3 and 2:548e549 Antimicrobial host defense, of MAIT cells 2:268e269 Antimicrobial peptides/proteins (AMPs) 1:285, 1:398e400, 1:424e427, 1:438, 1:444, 1:455, 1:457e458, 1:464, 1:487, 1:494, 1:505, 1:535, 2:557, 2:560e561, 4:77, 5:5e6, 5: 65, 5:112, 5:194 -activated protein kinase (AMPK) 3:38e39 as host-derived regulators of microbiota 1:402 of keratinocytes 3:445 Antimicrobial prophylaxis 5:488e489 Antimicrobial resistance (AMR) 4:2 Antimicrotubule monomethylauristatin E (MMAE) 4:552 Antinuclear antibody (ANA) testing 5:488 Anti-OX40 4:556t Anti-PD-1 4:412, 4:575 Anti-PD-1-blocking antibody 4:438e439 Antiproliferatives 5:259 Antisperm antibodies 5:51 Antithrombin III 2:340 Antithymocyte globulin (ATG) 5:256e257, 5:259, 5:266e267 Anti-TNF antibody 5:214 Antitumor antibody responses, Th cells and 4:444 Antitumor CD8 cytotoxic T cell response, Th cells and 4:444e445 Antitumor effector cells, CD4 T cells as 4:445e446 Antitumor immunity 4:479e481, 4:499e501, 4:570, 4:576e577 Antitumor responses of T-helper 9 cells 3:300e301 Antitumor therapies, interference with 4:496 Antitumorigenic immunity 4:411e412 Antitumorigenic Th1/M1 phenotype 4:410 Antiviral CD8 T lymphocyte responses 4:288 Antiviral cytokines, CD4 production of 4:293e294 Antiviral effect, activities unrelated to 2:489e490 Antiviral state 2:488 Anuran adaptive immunity, of amphibians 1:487e488 Aorta-gonad-mesonephros (AGM) region 1:1e2, 1:47e48",
            "cite_spans": [
                {
                    "start": 223,
                    "end": 467,
                    "text": "3:1e4, 3:17e18, 3:25, 3:211, 3:287e288, 3:321, 3:327, 3:353, 3:356, 3:374, 3:384, 3:435, 3:466e469, 3:493, 3:497e498, 4:83e84, 4:143, 4:208e209, 4:291e292, 4:441, 4:561e562, 5:13, 5:24e25, 5:31, 5:39e40, 5:55, 5:251e252, 5:379, 5:403e404, 5:474",
                    "ref_id": null
                },
                {
                    "start": 664,
                    "end": 669,
                    "text": "(mAb)",
                    "ref_id": null
                },
                {
                    "start": 1120,
                    "end": 1136,
                    "text": "65, 5:112, 5:194",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Atopic diseases Th2 effector functions in 3:297e298 Th9 effector functions in 3:299e300 Atopic eczema 1:385 Atovaquone 5:515 Atrophic thyroiditis 5:151, 5:151t Attenuation of inflammation and wound healing 5:32e33 ATX/LPA axis, lymphocyte extravasation regulation 3:535e536 Atypical chemokine receptors 2:579e585 and b-arrestin signaling 2:582 chemoattractants 2:580e581 expression and functional properties of ACKR1 2:579 of ACKR2 2:579e580 of ACKR3 2:580 of ACKR4 2:580 and G protein signaling 2:581 signaling properties of 2:581e582 structureefunction properties of 2:581 typical chemokine receptors and 2:579 Atypical hemolytic uremic syndrome 2:329 Aurelia aurita 1:400 Aurelin 1:400 Autoantibodies 3:240e241, 5: 168e170, 5:172, 5:204, 5:207, 5:212e213, 5 :220, 5:222e223, 5:446e447 Autograft 1:407e410, 1:408f Autoimmune arthritis, biologic targets in 5:216t Autoimmune cytopenia 5:429, 5:472 Autoimmune disease 2:434e435, 5:97, 5:133e149",
            "cite_spans": [
                {
                    "start": 718,
                    "end": 760,
                    "text": "168e170, 5:172, 5:204, 5:207, 5:212e213, 5",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Bregs in 4:475e478 and class I MHC molecules 2:175 complex autoimmune pathogenesis, model for 5:137 developmental factors 5:137f future directions 5:138e139 gene expression 5:138 improved GWAS analysis 5:138 intermediate phenotype analysis 5:138 systems biology 5:138e139 genetic contribution to autoimmunity, measuring 5:134e135 genome-wide association studies (GWAS) 5:135 heritability estimates 5:134 HLA association 5:134 genetics illuminate underlying biological pathways 5:137e138 common pathways leading to disease 5:137e138 disease-specific pathways 5:138 and HLA 2:297e301 IL-12/IL-23 cytokines in pathogenesis of 2:529 interferon-g and 2:497 mast cells in 1:317e318 missing heritability 5:135e137 common variants 5:135 environmental effects interacting with the genetic predisposition 5:136 epigenetics 5:136 epistasis 5:137 rare variants 5:135e136 somatic mutations 5:136e137 structural variants 5:137 monogenic autoimmunity due to impaired immune cell death and proliferation 5:146 due to impaired peripheral tolerance 5:147e148 related to dysfunctional innate immunity 5:142e146 related to failure in central tolerance 5:146e147 translational potential 5:139 diagnosis 5:139 disease stratification 5:139 therapeutics and personalized medicine 5:139 Autoimmune disuse 2:220e222 Autoimmune disorders complement in 5:505 Autoimmune encephalomyelitis (EAE) 4:173 Autoimmune enteropathy 5:446 Autoimmune inflammatory arthritis, animal models of 5:213e214 antigen-induced arthritis 5:214 collagen-induced arthritis (CIA) 5:213e214 Autoimmune lupus 5:97 Autoimmune lymphoproliferative syndrome (ALPS) 3:98, 3:101, 3:372, 5:146, 5:426, 5:471e472 biomarkers of 5:428 clinical features and treatments of 5:426e428 diagnosis of 5:429 FAS deficiency and 5:429e431 with Fas signaling defect 5:432 FASLG deficiency and 5:431e432 genetic and functional bases of 5:429e433 laboratory findings 5:428e429 related disorders 5:432e433 Autoimmune orchitis 5:51 Autoimmune polyendocrine syndrome 1 (APS-1). See Autoimmune polyendocrinopathy-candidiasisectodermal dystrophy (APS-1 or APECED) Autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy (APS-1 or APECED) 1:170, 3:395, 5:146e147, 5:411e412, 5:436e443 autoimmune regulator (AIRE) protein structure 5:436e437 clinical signs 5:438e440 chronic mucocutaneous candidiasis 5:439 ectodermal manifestations 5:440 endocrine manifestations 5:439 gastrointestinal manifestations 5:439 genetics of 5:437 immunological defects 5:438 mouse models 5:440 pathogenesis of 5:437e438",
            "cite_spans": [
                {
                    "start": 1360,
                    "end": 1365,
                    "text": "(EAE)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Autoimmune polyendocrinopathycandidiasis-ectodermal dystrophy (APS-1 or APECED) (continued) treatment 5:440 Autoimmune polyglandular syndrome type 1 (APS-1) 5:353e354 Autoimmune regulator (AIRE; Aire) 1: 170, 1:270, 3:393f, 4:435, 5:171e172, 5:353e354 in the thymic medulla 3:395 Autoimmune thyroid disease. See Thyroid disease, autoimmune Autoimmunity 1:86e89, 1:114e115, 1:361e362, 2:471e472, 2: 497, 2:566e567, 5:97, 5:172, 5:182, 5:184, 5:197e198, 5:276e277, 5:391, 5:437e438, 5:440, 5:444 immune response of CNS to 3:469e470 and inflammation 5:347 measurement genetic contribution to 5:134e135 genome-wide association studies (GWAS) 5:135 heritability estimates 5:134 HLA association 5:134 Autoimmunity, animal models of 5:227e240",
            "cite_spans": [
                {
                    "start": 204,
                    "end": 251,
                    "text": "170, 1:270, 3:393f, 4:435, 5:171e172, 5:353e354",
                    "ref_id": null
                },
                {
                    "start": 398,
                    "end": 493,
                    "text": "497, 2:566e567, 5:97, 5:172, 5:182, 5:184, 5:197e198, 5:276e277, 5:391, 5:437e438, 5:440, 5:444",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "BCR and TCR transgenic models 5:229e230 characteristics of multiple sclerosis 5:234e235 rheumatoid arthritis 5:233 systemic lupus erythematosus 5:231e232 type 1 diabetes (T1D) 5:233e234 general considerations in 5:227e228 humanized models 5:230e231 inducible models 5:230 monoallelic and transgenic spontaneous models 5:228e229 polygenic spontaneous models 5:228 Autoinfection 4:163 Autoinflammation and PLCgy2-associated antibody deficiency and immune dysregulation (APLAID) 5:471, 5:495te496t Autoinflammatory diseases (AID) 2:449, 5:494e503 AID associated with immunodeficiency 5:501 associated with immunodeficiency 5:501 classification and common clinical and biological manifestations 5:494 clinical and biological manifestations of 5:495te496t diagnosis 5:494 interferonopathies 5:500e501 chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature 5:501 interleukin-1 activation disorders 5:494e500 BS/early onset sarcoidosis 5:500 cryopyrin-associated periodic syndromes 5:497e498 familial Mediterranean fever 5:499 IL-1 receptor antagonist, deficiency of 5:500 mevalonate kinase deficiency 5:499 NAPS and CAMPS 5:500 NF-kB activation disorders 5:500 NLRC4 inflammasome mutations 5:500 pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) syndrome 5:499e500 misfolded protein disorders 5:500",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "tumor necrosis factor receptor-associated periodic syndrome 5:500 treatment 5:501e502 of CAPS, TRAPS, and MKD 5:501e502 of FMF 5:501 Autologous antigen-presenting cells (APCs) 4:501 4:120, 4:187, 4:187f, 4:190, 4:222, 4:441, 4:470, 5:3e5, 5:38, 5:41, 5:49, 5:59, 5:128t, 5:172, 5:186, 5:207, 5:254e255, 5:267, 5 adaptive immunity in 5:58e60 antigen presentation in the CNS 5:58 lymphocyte migration and control 5:59e60 lymphocytes and the brain 5:58e59 central nervous system (CNS) 5:56e58 macrophages and microglia activation in 5:56e58 mechanisms of pathogen-induced neural damage 5:56 pathogen entry into the brain 5:56 pathogens recognition 5:56 innate immune cells of brain natural killer (NK) cells 5:54e56 innate immune cells of the brain 5:54e56 astrocytes 5:55e56 dendritic cells ( 4:88e89, 4:97, 4:104, 4:137e138, 4:144, 4:146, 4:151, 4:193, 4:318, 4:403, 4:427, 4:430e431, 4:475e480, 5:25, 5:32, 5:40, 5:77, 5:152, 5:182, 5:185, 5:198e199, 5:220e223, 5:316, 5 in immigration and positioning in thymus 3:528 immune cell trafficking to secondary lymphoid tissues 3:528e531 blood-borne immune cell migration through high endothelial venules 3:528e530 lymph-borne immune cell migration to lymph nodes 3:530 migration and positioning of immune cells within secondary lymphoid tissues 3:530e531 inflammatory chemokines 2:575e576 in leukocyte homing 2:575e576 monocytes 3:528 neutrophils 3:527e528 presentation of chemokines and chemotactic cues 2:573e575 -producing reticular cell, in SLOs 3:475e476 receptors 1:518e519 in retention, emigration, and homing of immune cells in bone marrow 3:527e528 signaling chemokine receptors. See",
            "cite_spans": [
                {
                    "start": 182,
                    "end": 311,
                    "text": "4:120, 4:187, 4:187f, 4:190, 4:222, 4:441, 4:470, 5:3e5, 5:38, 5:41, 5:49, 5:59, 5:128t, 5:172, 5:186, 5:207, 5:254e255, 5:267, 5",
                    "ref_id": null
                },
                {
                    "start": 791,
                    "end": 970,
                    "text": "4:88e89, 4:97, 4:104, 4:137e138, 4:144, 4:146, 4:151, 4:193, 4:318, 4:403, 4:427, 4:430e431, 4:475e480, 5:25, 5:32, 5:40, 5:77, 5:152, 5:182, 5:185, 5:198e199, 5:220e223, 5:316, 5",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Chemokine receptor signaling spleen 3:528e529, 3:531 structure of 2:573f synergism 2:577 T cells 3:528e529 see also CD entries on porcine leukocytes 1:541t on porcine T cells 1:543t Cluster-type organization 2:160e161, 2:161f, 2:163 c-myc 2:494 c-myc + B cells 4:480 Cnidarians 1:398e399, 1:402e403 -associated microbial communities 1:401 defense molecules 1:399e401 antimicrobial peptides 1:399e400 apical epithelial cell surface 1:400e401 serine protease inhibitors 1:400 insights from corals 1:402e403 Insights from Hydra 1:403 and microorganisms 1:401e402 coral-associated microbial communities 1:401 rethinking the role of AMPs as hostderived regulators of the microbiota 1:402 tissue-associated microbial communities in hydra 1:401e402 as model systems in comparative immunology 1:397e398 MyD88-mediated signal transduction 1:399 NOD-like receptors 1:399 toll-like receptors 1:398e399 CSF-1R 2:586e587 granulocyte-colony stimulating factor (G-CSF) 2:587e589 function in immunity 2:588e589 ligand 2:587e588 receptor 2:588 granulocyte/macrophage-colony stimulating factor (GM-CSF) 2:589e590 function in immunity 2:590 ligand 2:589 receptor 2:589e590 interleukin-3 (IL-3) 2:590e591 function in immunity 2:591 ligand 2:590 receptor 2:590e591 structures of 2:588f Colony-forming unit (CFU) assays 1:27 Colorectal cancers (CRCs) 4:403, 4:535 Combination therapy 4:412 clinical consequences of complement deficiencies 5:507e508 clinical significance of 5:504e512 complement analysis 5:508e509, 5:509f excessive complement activation 5:504e507 in autoimmune disorders 5:505 and cancer 5:507 in nephropathies and renal graft rejection 5:505e506 in neural, ophthalmological, and dermatological disorders 5:506e507 in trauma, shock, and sepsis 5:504e505 therapeutic complement intervention 5:509e510 Complement components 1:329 C1, interaction of IgM with 2:7 Complement organization and function 2:341 Complement pathway, inflammatory products of 2:332e336 acute versus chronic inflammation 2:334e335 humoral immunity 2:335 T cell immunity 2:335 anaphylatoxins 2:334 complement as key driver of inflammation 2:332e333 evolving view on complement in inflammation 2:335e336 immune homeostasis and tissue repair, complement in 2:335e336 Immune cell egress and ingress, regulators of 3:533e536",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "adhesion 3:535 fibroblastic reticular cell (FRC) 3:534 high endothelial venule (HEV) 3:533 lymph node 3:535e536 lymphocyte extravasation ATX/LPA axis regulating 3:535e536 lysophosphatidic acid (LPA) 3:534e535 receptors 3:533 rolling 3:535 sphingosine-1-phosphate (S1P) 3:533e534 S1P receptors 3:533e535 transmigration 3:535 Immune cell trafficking to secondary lymphoid tissues 3:528e531 blood-borne immune cell migration through high endothelial venules 3:528e530 lymph-borne immune cell migration to lymph nodes 3:530 migration and positioning of immune cells within secondary lymphoid tissues 3:530e531 Immune cells 5:192e193 androgen receptors in 5:96 estrogen receptors in 5:96 Immune checkpoint inhibitors 4:576e577 Immune complexes (ICs) 3:181e182 Immune Epitope Database and Analysis Resource (IEDB) 2:220e224 accessing the data 2:222e223 data content and structure 2:220e222 Immune evasion 4:275 by T. cruzi 4:111e112 Immune modulation 4:150e151, 5:339 Immune pathology 4:255e256 Immune priming 1:448 phenomenon of 1:446e447 potential mechanism(s) of 1:447e448 Immune privilege 1:302e303, 5:46 anatomical barriers that contribute to 5:24 in anterior chamber (AC) of eye 5:24e26 of corneal allografts 5:26e27 importance of 5:27e28 physiological conditions that contribute to 5:24e26 testicular structure in favor of 5:47 Immune receptor signaling, adapter molecules in 3:9e15 B cell signaling, overview of 3:13 linker of activated T cells (LAT), structure and function relationship of 3:10e11 SLP-65 and its associated binding partners 3:13 Src homology 2 (SH2) domain-containing leukocyte protein of 76 kDa (SLP-76) amino-terminus 3:11e12 carboxy-terminus 3:12 central domains 3:12 dynamic regulation of LAT and SLP-76-nucleated complexes 3:12e13 as a T cell receptor 2:162e163 Ig superfamily (IgSF) 1:508, 2:160, 2:162f members, blood vascular endothelium 3:515e516, 3:515te516t Ig tail tyrosine (ITT) motifs 3:44 Ig V genes 1:476e477 IgA 1:518, 2:23, 5:5, 5:110, 5:112e113, 5:115e116 deficiency (IgAD) 2:23 induction in gut 2:25e26 interaction with pIgR 2:7 -isotype-switch recombination, regulation of 1:137 monocytic properties 2:28 nephropathy 5:506 plasma cell functions 2:28 plasma cells 2:26e27 -secreting B cells 3:153 supercoating, effect of 2:27 'Western' diets and 2:28 Ig-a (CD79a) 1:57, 3:13, 3:191 Igb 1:57 Igb (CD79b) 3:13 IgD 3:230 IgE 2:31e39, 3:297, 5:298, 5:306e307, 5:321e322 abundance and half-life of 2:31 -activated basophils 1:330e331 anaphylaxis 2:32e33, 2:35e36 antibodies 4:166 anti-IgE therapeutics 2:36 asthma 2:35e36 cross reactivity between helminths and allergens 4:170 e gene CSR, regulation of 2:33e35, 2:34f -facilitated antigen presentation (IgE-FAP) 5:317 GLT, regulation of 2:35 -mediated mast cell activation 1:312 molecular structure of 2:31 paradox 3:197 production 4:142 receptor (FceRI) 1:326e327 receptor and effector function 2:32e33 relation to atopy and parasitic infections 5:329e330 response, pathophysiology of 2:35e36 soluble versus membrane IgE 2:31e32 therapies targeting 2:36 and TI antibody response 3:230 type I hypersensitivity 2:35e36 IgG 1:518, 2:15e22, 2:16f, 5:97 -antibodies to deamidated gliadin peptides (IgG-DGP) 5:222e223 C1 binding site of 2:7 fold 2:15e17, 2:17f function 2:18e19 regulation of immune response 2:10 response to TI antigens 3:227, 3:231e232 structure overview 2:15 subclasses 2:18e19, 2:19f variable domains 2:17e18 IgG + memory B cells 1:89 in European rabbits 1:519e520 IL-1 1:499, 2:438e446, 4:125e126, 4:408e409, 4:411, 5:194, 5:253 adaptive immunity cells 2:441 allergic response 2:441 autoimmune disease 2:441 autoinflammatory disease 2:440e441 caspase-1 2:440e441, 2:443 decoy receptor 2:442e444 inflammasome 2:440 innate and adaptive lymphoid cells, polarization of 2:443e444 mitogen-activated protein kinases (MAPKs) 2:439, 2:442 negative regulation of 2:442e443 NF-kB 2:441 orchestration of IL-1-mediated immune and inflammatory responses by neutrophils 2:443 receptor (IL-1R) 2:598e599, 5:253 receptor antagonist 2:439 receptor antagonist, deficiency of 5:500 IL-1, activation disorders 5:494e500, 5:495te496t BS/early onset sarcoidosis 5:500 cryopyrin-associated periodic syndromes 5:497e498 familial Mediterranean fever (FMF) 5:499 IL-1 receptor antagonist, deficiency of 5:500 mevalonate kinase deficiency (MKD) 5:499 NAPS and CAMPS 5:500 NF-kB activation disorders 5:500 NLRC4 inflammasome mutations 5:500 pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) syndrome 5:499e500 IL-1a precursor 2:440 IL-1b 2:447, 4:135, 4:517e518, 5:494e497 IL-1R 2:439e442 interleukin-1 2:439e441 interleukin-18 2:441 interleukin-33 2:441 interleukin-36 2:441e442 interleukin-37 2:442 interleukin-38 2:442 and toll-like receptor signaling 3:54e56 IL-1R8 2:443 IL1ra gene 2:549t IL-1RAcPb 2:443 IL-1R-associated kinase (IRAK) 1:399, 3:110e111 IL-1R-associated kinase-4 (IRAK-4) 1:411, 5:410e411 IL-1RI 3:289e290 Il1rl1 gene 1:152e153 IL-2 1:194, 1:383e384, 2:510e512, 3:244e245, 3:323, 3:356e357, 4:256e257, 4:452, 4:561, 5:328 and TI antibody response 3:230 IL-2einducible T cell kinase (ITK) deficiency 4:381 IL-2R 5:285e286 IL-3 1:327e329, 1:336, 2:590e591 function in immunity 2:591 human IL-3 gene 2:590 in vitro IL-3 2:591 ligand 2:590 IL-3R 2:590e591 IL3Ra 2:591 IL-4 1:194, 1:294, 1:329, 1:381, 1:383, 2:512, 3:25, 3:245e246, 3:337, 4:137e138, 4:166, 5:266, 5:298 cellular and molecular network of 2:519 cellular effects of 2:520e522 production and sensing 2:519e520 signaling 2:519e521, 2:521f, 2:523, 3:294 and TI antibody response 3:230 IL-4/STAT5 activation and 3:294e295 IL4I1 3:289e290 IL-4R, type II 3:294 IL4Ra 2:549t, 2:550 IL-4Ra pairs 3:128 IL-5 1:381, 1:383, 1:385, 4:166, 5:298 biology of 1:336 and TI antibody response 3:230 IL-5R 3:136 Interleukin (IL) (continued) IL-6 1: 329, 1:499, 3:249e250, 3:339, 4:223e224, 4:227, 4:411, 4:517e518, 5:5, 5:252, 5 :266 cytokine function, proteolytic regulation of 2:478e479 IL-6 family of cytokines 2:476e478 inflammatory cytokines 2:476 inhibition of IL-6 signaling 2:479e480 pro-versus anti-inflammatory IL-6 signaling 2:480e481 in rabbits 1:519e520 sgp130Fc 2:476, 2:480e481 shedding 2:479 signaling 3:129e131 trans-signaling 2:477e481, 2:480f, 2:481t IL-7 1:40e41, 1:49, 1:55, 1:383, 2:100, 2:512, 3:357, 3:384, 5:89 and double-negative T precursor cell homeostasis 1:193 expression in thymus 1:193 and Notch signaling 1:187e188 in rabbits 1:520 signaling 1:151, 5:361e362 IL-7R 3:353e354 signaling 1:66, 1:193e194 IL-7Ra-deficient SCID 5:364e365 clinical presentation and diagnosis 5:364e365 treatment 5:365 IL-7/STAT5 signaling 1:67e68 IL-8 1:499, 4:44, 4:223e224, 4:227, 4:344 IL-8-producing CD4 + cells 5:104 IL-9 1:381, 1:384, 2:512e513, 3:294, 3:298e299, 5:298 IL-10 1:552, 2:544e554, 3:131, 3:227, 3:247, 3:270e272, 3:322e323, 3:340, 4:46e48, 4:128e129, 4:168, 4:223e224, 4:227, 4:256e257, 4:293e294, 4:327e329, 4:452, 4:478e480, 4:527, 5:47e48, 5:194, 5:276, 5 :445 cancer and 4:527e528 cells responsive to 2:546 gene 2:544t, 2:546, 2:549t genes induced by, in macrophages 2:549t genetic toolbox to dissect 2:544 genetics and 2:544e546 intestinal homeostasis and 2:544e545 microbe-triggered production 5:339 -producing Tregs 1:361e362 -producing type 1 regulatory T (Tr1) cells 5:313, 5:315 receptor deficiency 2:545 -regulated genes 2:549 regulation of intestinal inflammation by 2:545f restricting effective immunity to pathogens 2:545e546 signaling 4:120 signaling, deficiency in 5:148 Socs3 and AIR 2:548e549 sources of 2:546 IL-10 + Bregs 4:479e480 IL-10-mediated AIR 2:547e550 acting at the level of transcription 2:548 gene specific, AIR as 2:547e548 requiring new protein synthesis 2:548 IL-10R 2:544 IL-10 signaling compared to other receptors that activate JAK1 and STAT3 2:547 and its proximal signaling pathway 2:546e547 and its relationship to other cytokine receptors 2:546 proximal IL-10 signaling via JAK1 and STAT3 2:546e547 structure of 2:546 IL10ra 2:544e545, 2:544t IL10rb 2:544t, 2:545 IL-10-TB connection 2:546 IL-11 4:411 IL-12 3:339, 4:125e126, 4:128e129, 4:223e224, 4:227, 4:518e521, 4:519te520t production of 5:89e90 receptor signaling, limiting by CD4 + T cells 5:90e91 TLR-induced 4:125e126 IL12b, transcription 2:547, 2:550 Il12b, inhibition 2:550 IL-12/IL-23 cytokine family 2:525e533 and cancer 2:530e531 cellular sources of 2:527f effects on tumor growth 2:531f expression and signaling of 2:526e528 genetic variations in autoimmune diseases 2:529e530 immunoregulatory activities of 2:528e529 in pathogenesis of autoimmune diseases 2:529 and receptors 2:525e526 structure of 2:526f IL-12p40 4:135 IL-12R 2:527, 3:287e289 IL12RB1 5:409 IL-13 1:381, 1:383, 1:385, 3:247, 3:270, 4:137e138, 4:166, 5:298, 5:324e325, 5:337 cellular and molecular network of 2:519 cellular effects of 2:520e522 -mediated mucus production 3:297 production and sensing 2:519e520 signaling 2:519e521, 2:521f, 2:523 IL-15 1:194e195, 2:513e514, 3:357e358, 3:384, 4:223e224, 4:227, 5:222 IL-17 1:212, 1:382e383, 2:525, 3:329, 3:331, 3:337e339, 4:119, 4:137e138, 4:293e294, 4:411, 4:518 antimicrobial immune response 2:539 in diseases and its clinical significance 2:539e540 family 2:534e535, 2:537f innate-producing cells 2:535e536 -mediated immunity, ingherited disorders of 5:411e412 neutralization 4:519te520t pathogenesis of psoriasis 2:540 producing cells 2:535e536 receptor family 2:536e537 -secreting group 3 ILCs (ILC3s) 2:536 signal transduction of receptor family 2:536e539, 2:538f target cells and genes of 2:539t IL-17A 2:540, 3:289e290, 3:310, 3:312, 5:197e198, 5:299 IL-17F 2:540, 3:310, 3:312, 5:299, 5:407 IL-17R 5:407 IL-17RA 2:540, 5:407, 5:411e412 IL-17RC 5:299 IL-17RE 3:289e290 IL-18 1:329, 2:447, 2:602, 3:338 IL-19 2:554, 2:559e560 IL-20 2:554, 2:559e560, 5:194 cytokine receptors 2:556e557 IL-20 subfamily cytokines 2:555f, 2:555t, 2:557fe558f, 2:558t, 2:560f genomic localization, structure, and expression 2:554e556 subfamily cytokines, emerging functions of 2:561 wound healing, inflammation, host defense 2:557e559 IL-21 1:112e113, 2:514e515, 3:247e248 adaptive immune responses 5:5e9 anatomy of 3:428f, 5:2e3, 5:3f antibody responses in 5:6e9 antigen uptake route 5:7f antigen-specific immunity 5:6 diet impact on 5:9e11 embryonic 2:544e545 host-microbiota interactions in 5:10f IgA transport and function in 5:8f IL-10R signaling in 2:544 immune apparatus 5:3f immune effector responses in 5:6e9 innate immune response 5:4e5 microbes, impact on 5:9e11 myeloid effector cells in 5:5 organized lymphoid tissues of 5:3e4 physiology of 5:2e3 scattered immune cells in 5:4 T cell responses 5:9 See also Gut immune system Intra-aortic cluster 1:3 Intracellular adhesion molecule (ICAM) family 3:72 Intracellular death domain (ICD) 5:429e430 Intracellular Notch (ICN) 1:182e184 Intracellular Toll/IL-1 receptor (TIR) domain 3:54e55 Intracellular trafficking 2:119e120 MR1 2:267e268 Intraepithelial compartment 3:430e431 induced APC activation and maturation 1:360e361 iNKT17 cells 1:220 innate and adaptive immunity cells and soluble factors regulated by 1:361f interaction with CD1d-expressing DC 1:360 in pathogenesis of aGVHD 1:364f pathogen-related iNKT cell responses 1:361e362 protective impact of 1:362e365 regulatory networks 1:360e362 role in immunity 1:362e365 role in infection 1:363t thymocyte selection 1:242, 1:246e247 Treg interaction and 1:361e362 Invasive infections 5:346 Invasive nontyphoidal salmonellosis (iNTS) 4:53 Invertebrate peptidoglycan recognition proteins 2:398e399 functions 2:398 genes, proteins, and expression 2:398 Ionizing radiation, for cancer therapy 4:576 IPEX-like syndromes 5:147, 5:447 Ipilimumab 4:427e428 IRAK4 deficiency 5:410e411 IRAK4-MYD88 signaling pathway 5:346 Irf8/PU.1 3:203 IRGM 5:5 Iron, deprivation of 1:285 Iron-binding protein 1:285 Ischemia-reperfusion injury (IRI) 1:297, 5:251, 5:266 reactive intermediates in 1:297e298 Ischemic stroke 1:354e355 and CNS 3:466, 3:470e471 Isekizumab 2:540 ISG factor 3 (ISGF3) complex 4:228e229 ISG15 2:488, 5:409 ISG15 deficiency 5:145 Islet antigen 2 (IA-2) antibodies 5:160 Isolated lymphoid follicles (ILFs) 2:23, 3:429e430, 5:3e4 Isolated T celleindependent antigens 3:231 Isopentenyl pyrophosphate (IPP) and TCRgd activation 2:79 Isoprenoid biosynthesis, mevalonate pathway of 2:79f Istradefylline 2:429 ITCH deficiency 5:147 ITGA7 + pericytes (IAPs) 3:476 ITK 5:393 ITK deficiency 5:393e394 ITreg generation 3:153 J J chain, IgM 2:2, 2:4e5 Jak protein tyrosine kinases 2:494, 2:600e601, 3:134e138, 3:135f JAK1",
            "cite_spans": [
                {
                    "start": 5799,
                    "end": 5878,
                    "text": "329, 1:499, 3:249e250, 3:339, 4:223e224, 4:227, 4:411, 4:517e518, 5:5, 5:252, 5",
                    "ref_id": null
                },
                {
                    "start": 6803,
                    "end": 6937,
                    "text": "3:340, 4:46e48, 4:128e129, 4:168, 4:223e224, 4:227, 4:256e257, 4:293e294, 4:327e329, 4:452, 4:478e480, 4:527, 5:47e48, 5:194, 5:276, 5",
                    "ref_id": null
                },
                {
                    "start": 12200,
                    "end": 12205,
                    "text": "(IPP)",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "IL-10 signaling that activate 2:547 proximal IL-10 signaling via 2:546e547 JAK2 2:547 JAK3 2:547 JAK3-deficient SCID 5:363e364 clinical presentation and diagnosis 5:363e364 Janus homology domains 5:363e364 missense mutations in 5:361 treatment 5:364 JAK-STAT cytokines 4:227e228 a-helical cytokine fold 3:125 structural features 3:125e127 archetypal growth hormone receptor signaling complex 3:127 class 1 cytokineereceptor complexes 3:128e131 bC clinical implications of KIR-HLA interactions 1:377e378 clonal expression 1:376e377 distribution of A and B 1:373e374, 1:374f genomic organization 1:371e372 genotypes in populations 1:373f haplotypes 1:372e373, 1:372f in HIV-1 infection 4:263e266 ligands 1:375e376 nucleotide polymorphism of genes 1:373e374 sequence polymorphism of 1:374, 1:374f Killer cell lectin-like receptor family G member 1 (KLRG1) 3:40, 3:353e354 Killer cell lectin-like receptors (KLR) 1:371 expressed as heterodimers 1:371 Killer cells 3:364e365, 3:365f, 3:367 groups 3:364e366 Kim-1, expression of 3:83 Kinapses 3:16 Kinase and phosphatase effector pathways connecting proximal TCR signaling to 3:25e26 in T cells 3:25e37 eicosanoids, nuclear receptors, and fatty liver disease 1:296e297 functional heterogeneity 1:293e294 in hepatic fibrosis and liver regeneration 1:298 in hepatic pathophysiology 1:297f in immune responses 1:298t in liver 5:13 as the liver sinusoidal firewall 1:294e295 origins of 1:293e294, 1:294f reactive intermediates in ischemia reperfusion injury 1:297e298 tumor necrosis factor superfamily (TNFSF) members, death by 1:295e296 Kuru 4:185t KxB/N 5:233 KxB/N serum transfer 5:230 Kynurenine 4:40 L Laboratory of genetics and physiology 2 (LGP2) protein 1:520, 2:352 Lactadherin 3:86 Lactobacillus 4:167 Lactobacillus casei 5:330e331 Lactobacillus reuteri 5:330e331 Lactobacillus rhamnosus GG 5:330e331 Lactoferrin 1:285, 4:77 Lagomorph Genomics Consortium (LaGomiCs) 1:515 Lagomorphs adaptive immune system in 1:516e518 comparisons of European rabbit with other lagomorphs 1:517e518 comparisons of European rabbit with other mammalian models and chicken 1:516e517 contributions to basic immunology from studies in European rabbit 1:516 advantages of 1:520e521 development and testing of therapeutics and preclinical investigations 1:521 rabbit lentiviruses and HIV 1:520 transplantation and tolerance 1:520e521 allelic allotypes, use of 1:516 chemokines and their receptors 1:518e519 innate immune system in 1:518e520 genetic characterization of host factors in hostepathogen interaction 1:518e520 order Lagomorpha 1:515e516 Lambda light chain locus 2:62, 2:64 human 2:66 mouse 2:67 rearrangement and expression 2:64e65 Lamellipodia 5:418e419 Lamellocytes 1:457 Lamellopodia 3:75 Lamina propria (LP) 2:23e24, 2:24f, 3:430, 5:2e3, 5:5",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "balance between effector and Tregs in 5:9 plasma cells in 3:205e206 T cells 5:9 Lamina propria lymphocytes (LPL) 1:538 Lamotrigine hypersensitivity 2:313 Lamprey 1:468, 1:470e471, 2:148 sequential assembly by copy-choice templating in 2:147 VLRB clones 2:150e151 Langerhans cells (LCs) 1:345, 1:349e350, 1:540, 4:207, 4:499e502, 5:30e33, 5:192e193, 5:195e197, 5 Lymphatic vasculature, endothelial adhesion molecules in 3:520e526 adhesion molecules of LECs within the lymph node 3:524e525 afferent LECs adhere to the matrix via anchoring filaments 3:521e522 afferent lymphatics 3:520 anchoring filaments 3:521e522, 3:521f button-type junctions 3:520 dendritic cell trafficking via afferent lymphatics 3:522e523 efferent lymphatics 3:520, 3:524 inflammation-induced changes in lymphatics 3:523e524 junctional interendothelial adhesion molecules in afferent LECs 3:522 LEC adhesion molecules in the remodeling of collecting lymphatics 3:522 leukocyte traffic 3:524 lymphatic endothelial cells (LEC) 3:520e521 lymphocyte migration through lymphatic vessels 3:523 sinusoidal endothelium 3:524 Lymphatic vessels 3:481 dermal 3:448e449 3:446f, 4:70e71, 4:143, 4:441, 4:496, 5:4e6, 5:38e39, 5:49, 5:57e58, 5:65e66, 5:122e123, 5:127, 5:130, 5:182, 5:187, 5:198, 5:297 309e325, 2:521e522, 5:38, 5:40, 5:49, 5:198, 5:292e293, 5:298, 5:307e308 activation, and mediator production 1:312e316 in adaptive immunity 1:316 in allergic disease 1:316e317 in autoimmune disease 1: 3:434, 4:35e36, 4:110, 4:135, 4:207, 4:222, 4:243, 4:253e261, 4:344, 4:366, 4:407e408, 4:411, 4:462, 5:41, 5:54e56, 5:66, 5:250, 5:253, 5:266, 5:276, 5:400e401, 5 ",
            "cite_spans": [
                {
                    "start": 304,
                    "end": 361,
                    "text": "1:540, 4:207, 4:499e502, 5:30e33, 5:192e193, 5:195e197, 5",
                    "ref_id": null
                },
                {
                    "start": 990,
                    "end": 995,
                    "text": "(LEC)",
                    "ref_id": null
                },
                {
                    "start": 1129,
                    "end": 1258,
                    "text": "3:446f, 4:70e71, 4:143, 4:441, 4:496, 5:4e6, 5:38e39, 5:49, 5:57e58, 5:65e66, 5:122e123, 5:127, 5:130, 5:182, 5:187, 5:198, 5:297",
                    "ref_id": null
                },
                {
                    "start": 1259,
                    "end": 1331,
                    "text": "309e325, 2:521e522, 5:38, 5:40, 5:49, 5:198, 5:292e293, 5:298, 5:307e308",
                    "ref_id": null
                },
                {
                    "start": 1460,
                    "end": 1622,
                    "text": "3:434, 4:35e36, 4:110, 4:135, 4:207, 4:222, 4:243, 4:253e261, 4:344, 4:366, 4:407e408, 4:411, 4:462, 5:41, 5:54e56, 5:66, 5:250, 5:253, 5:266, 5:276, 5:400e401, 5",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "NF-kB essential modulator (NEMO) 3:54e60, 3:116e118, 5:410 NF-kB1 3:116e118, 5:473 NF-kB2 3:118, 5:473e474 NF-kB-inducing kinase (NIK) 1:109e110, 3:118, 3:261e263, 3:262f Nfkbid gene 2:549t Nuclear factor Y (NF-Y) 5:380 NGAL 1:285 NHEJ1 (Cernunnos/Xlf) 5:374 Nickel 5:292e293 Nicotinamide 5:122 Nicotinamide adenine dinucleotide phosphateoxidase (NADPH) complex 4:118, 4:515 NIDO-AMOP-VWD mucins 2:386 19S",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "/CD94 receptor 4:255 NKG2C + natural killer (NK) cells 4:249 NKG2D 4:435, 5:9 NKG2D ligands 2:274e275, 3:330 NKG2D receptor 1:354e355 NKG2D-mediated recognition by NK cells 4:266",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "NKp46 + CD3 + T cells 1:536 NKT1 1:359e360 NKT2 1:360 NKT10",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Parenchymal basement membrane, of CNS 3:466e467 Paroxysmal nocturnal hemoglobinuria (PNH) 2:330, 5:508 PARSIFAL study 5:330",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Parthenium (feverfew) 5:284 Partial DiGeorge syndrome (pDGS) 5:352e354 immunodeficiency in 5:353e354 Passenger mutations 4:426 Passive cutaneous anaphylaxis (PCA) 2:365 Passive immunity 1:504 Passive systemic anaphylaxis (PSA) 2:365 Passive transfer MG (PTMG) 5:171 Pathogen entry into brain 5:56 Pathogen recognition receptors (PRRs) 4:291",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "252 Pathogen-derived products 1:329, 2:69 Pathogenesis-related proteins (PRs) 5:284 Pathogen-induced neural damage, mechanisms of 5:56 Pathogen-mediated activation 1:314e316 direct pathogen recognition 1:314e315 indirect pathogen recognition 1:315e316 Pathogens diversity of 4:1f and MZ B cells 3:216, 3:218, 3:221 recognition",
            "authors": [],
            "year": null,
            "venue": "-activated signaling pathways 4:203e204 in antifungal defense 4:76t, 4:77e79 role of C-type lectin receptors (CLRs) in antifungal immunity 4:78e79 role of NOD-like receptors and the inflammasome in antifungal immunity 4:79 role of TLRs in antifungal immunity",
            "volume": "5",
            "issn": "",
            "pages": "210--211",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Pax5-deficient progenitor cells 1:42 Pax9 1:175 PAXX 5:374e375 PcG complexes 1:31e33 Peanut-specific IgE 4:169e170 P-elements, and C-NHEJ end processing",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Keytruda) 4:427e428 Pemphigus vulgaris (PV) 2:299 Penaeus monodon 1:444 Penicillin",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Pembrolizumab",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "221--222",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Pneumococcal genome 4:60e61 Pneumococcal histidine triad D (PhtD) 4:63e64 Pneumococcal infection",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Pneumococcal Molecular Epidemiology Network 4:60e61 Pneumococcal pneumonia 4:61e63 carriage events 4:61e62 epidemiology of 4:61e62 innate defense against 4:63 macrophages in protection against 4:63 progression from pneumococcal carriage to pneumonia 4:61e62, 4:62f",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "63--64",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "534 Podosome 5:418e419 Pol zeta 1:477e478 Poliovirus (PV) 4:288 vaccine for 4:390t Poliovirus receptor (PVR)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Polyclonal B cell activation 4:104 Polycomb group (PcG) subunits 1:31 Polycomb repressive complex 2 (PRC2) 1:31",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Polycomb repressive deubiquitinase",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "31--33",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Polyendocrinopathy candidiasis ectodermal dystrophy, autoimmune 5:146e147 Polyethylene glycol (PEG) 2:274 Polyethylene glycol-conjugated ADA",
            "authors": [],
            "year": null,
            "venue": "PEG-ADA",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Polygenic spontaneous models 5:228 Poly-ICLC",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Polymerization actin 3:90 depolymerization of ZPS 3:227 Polymorphisms in classical MHC molecules 2:305e306 in HLA-DRB1 gene 2:196f in MHC class I genes 2:174e176 in MHC class II genes",
            "authors": [],
            "year": null,
            "venue": "Polyimmunoglobulin receptor (pIgR) 2:4, 2:23, 4:282, 5:7, 5:112e113 interaction of IgA with 2:7 interaction of IgM with 2:7 molecular requirements for forming",
            "volume": "2",
            "issn": "",
            "pages": "209--210",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Polymorphonuclear neutrophils (PMNs) 1:540 Polyomavirus",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Polyproline type II conformation 2:192e193 Polysaccharides 3:216, 3:227 zwitterionic. See Zwitterionic polysaccharides (ZPSs) Population dynamics 4:20 Porcine immune system 1:538 primary lymphatic organs 1:538 secondary lymphatic organs 1:538 lymph nodes 1:538 mucosa-associated lymphoid tissue (MALT)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Peyer's patches 1:538 spleen",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Porcine leukocytes, cluster of differentiation",
            "authors": [],
            "year": null,
            "venue": "CD) markers on",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Porcine NOD (poNOD) 1:539 Porcine reproductive and respiratory syndrome virus (PRRSV)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "cluster of differentiation (CD) markers on 1:543t Poribacteria 1:413 Porifera",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Porcine",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Cells",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Porins 3:231 Porites compressa 1:401 Portal venous tolerance 1:295, 1:297f Positive selection 1:255e256, 1:277e278 migratory cues impacting DP cells undergoing 1:255e256 TCR signaling during 1:243f, 1:244e245 on thymocyte migration and medullary entry",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "256--257",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Positive thymocyte selection, TCR signaling during 1:243f, 1:244e245 Postcapillary venules and blood vascular endothelial adhesion molecules 3:514 dermal 3:448 Postcleavage complex (PCC) 5:371e372 Postcleavage synaptic complex (PSC) 2:107 Posterior signaling center (PSC) 1:455 Postmeiotic segregation 2 (PMS2) 2:130, 5:479e480 deficiency 5:482 Postpartum thyroiditis 5:152 Post-rearrangement diversification mechanisms",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Pre-B cell receptor (Pre-BCR) 1:48, 2:100 and B cell receptor 2:43f signaling pathway 1:67e68, 5:461e462 B cell linker (BLNK)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "BTK) 5:461e462 structure, alterations of 5:459e461 IGHM alterations 5:460e461 IGLL1, CD79A, and CD79B alterations",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Bruton&apos;s Tyrosine Kinase",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Precursor B cell acute lymphoblastic leukemia (pre-B-ALL",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "279--280",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Precursor B cell receptor (pre-BCR) 1:57e63 activation of 1:58 in autoreactivity 1:60e61 in HC allelic exclusion 1:60 serving quality control of newly generated Ig heavy chains 1:60 signaling downstream of 1:58e59 structure of 1:57e58 supporting efficient B cell development 1:60",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "PXR) 3:147 Pregnant uterus, immune privilege of 5:80e81",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Pregnane",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Receptor",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Preimmune B cells 1:94e95 selection",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Pre-ligand association-domain (PLAD) 5:429e430 Preloading complex 2:235 Premalignant lesions 4:543e544 Premature aging 5:453 Preparative chemotherapy 5:365 Present-in-SAS6 (PISA) 5:373e374 Pre-T cell receptors and b-selection checkpoint 1:237 and gd TCR characteristics",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "helper cells 3:211 Pretransplant conditioning 5:516 Prevenar",
            "authors": [
                {
                    "first": "-T",
                    "middle": [],
                    "last": "Pre",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "513 affecting interferon (IFN)-g-mediated immunity 5:407 biological guidelines 5:348e349 clinical guidelines 5:346e347 allergy 5:347 associated features 5:347 autoimmunity and inflammation 5:347 bacterial infections",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Pristane 5:232 PRKCD 5:372e373, 5:471e472 PRKCd deficiency 5:471e472 Prnp expression 4:187e188 PRNP gene 4:185, 4:188 Pro-B cells 1:106e107 Probiotics 1:448, 5:11, 5:342 Procaspase-8 5:426 Procaspase-10 5:426 Professional antigen-presenting cells (pAPCs) 4:288",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Profibrotic Th2 cytokines 1:298 Profilins 5:284e285 Profound T cell dysfunction 5:513 management of 5:513e517 Progesterone 5:77 Progesterone receptor",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Progesterone-based contraceptives 5:69 Programmed cell death protein 1",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "PD-1/PD-L1-mediated adaptive immune resistance",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "438--439",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "TRB gene 2:88 Programmed death ligands PD-L1 2:28, 4:546e547, 5:15, 5:25e26 -induced Tcell apoptosis",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Pdb1",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Prolactin-induced protein (PIP) 2:274 Prolamin superfamily 5:284 Proliferating cell nuclear antigen (PCNA) 2:127e130 K164 of 2:130 monoubiquitylation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Proliferator-activated receptor a (PPARa) 2:377, 4:479 pathway",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Proliferator-activated receptor g (PPARg) 3:534e535 Proline serine threonine phosphatase interacting protein 1 (PSTPIP1) 5:499e500 Proline-rich region",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Proline-rich sequence (PRS) 3:1e2 Promyelocytic leukemia zinc finger (PLZF) 1:151, 1:159 deficiency",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "1:151 in gd T Cells 1:221 mutations that enhance 1:221e222 Zbtb16 expression and function 1:213, 1:220e221 development of innate T Cell effector functions",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Plzf + Chilps",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Prophenoloxidase-activating system (proPO) 1:423, 1:438, 1:442e444 -activating enzyme (ppA) 1:442e443 Prophylactic cancer vaccines 4:543e544 Prophylactic therapy and screening 4:410 Prophylactic vaccination 4:104e105 Prostaglandin D2 (PGD2) 1:383",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Prostaglandin E2 (PGE2) 4:135, 4:517, 4:527 inhibitors",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "519--520",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "APC) 2:340e341 Protein cross reactivity 4:169 Protein Data Bank 5:285 Protein defenses of skin 5:31 Protein digestion in formation of ligandome 2:211e212 Protein islands 2:47e48 Protein kinase A 2:433",
            "authors": [],
            "year": null,
            "venue": "Protective nonneutralizing antibodies 4:347e348 Protein C (PC) 2:340 activated PC",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "ProS) 5:48 Protein tyrosine kinases (PTKs) 3:1 Protein tyrosine phosphatase nonreceptor type",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Protein",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "22",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Protein tyrosine phosphatases (PTPs) 3:4 Protein tyrosine phosphatase-zeta (PTP-zeta",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Protumorigenic lymphocytes 4:411 PROVENGE 4:501 Prox1",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Proximal IL-10 signaling via JAK1 and STAT3",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "546--547",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "PRR-triggered immunity (PTI) 1:391 Prx1-Cre 3:402 PRY-SPRY domain 4:236e237 P-selectin (CD62P) 3:76e77",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "512--514",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "P2 synthesis 3:89 PTPN22 5:214 PTS domains (proline, threonine, and serine-rich domains) 2:381 PU",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Pu.1-expressing cells 1:38e40 PubMed 2:220e221 Puma 3:98e99 and thymocyte selection 1:246 Puncta",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "27--28",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Pure NK cell deficiencies 4:378e379 Purkinje cells 2:579 Pyogenic arthritis 5:499e500 Pyogenic sterile arthritis, pyoderma gangrenosum and acne (PAPA) syndrome 5:495te496t, 5:499e500 Pyridoxal",
            "authors": [],
            "year": null,
            "venue": "See Vitamin",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "See Vitamin B6",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Pyridoxamine",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "See Vitamin B6 Pyrimidine intermediates 2:267 Pyrin and HIN domain-containing proteins (PYHIN) family",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Pyridoxine",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Pyruvate dehydrogenase kinase (PDHK1) 3:41 Python molurus bivittatus 1:495 Rheumatoid factor (RF) 5:212 Rhinitis. See Allergic rhinitis Rhinosinusitis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Rho GTPase mutations 5:420 Rho GTPase Rac",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "RhoA-Rock signaling 1:5e7 Rho-family guanine-nucleotide exchange factors (GEFs) 3:86 RHOH deficiency 5:396 RhoH mutation in epidermodysplasia verruciformis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "See Vitamin B2 Ribonucleases eosinophil cationic protein (ECP) 1:334e335 Rilotumumab 4:552 RING domain 4:236 Ring finger protein",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Riboflavin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "8",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "RNA exosome 3:188e189 RNA genome 4:366 RNA interference (RNAi) 1:460 RNA pol III 4:203 RNA processing, activation-induced deaminase (AID) and 2:121 RNA silencing 2:118 RNA splicing 2:57 RNA vaccines 4:546 RNA viruses, CNS infection 4:333t RNA-based immunity 1:460 RNA",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Rituximab",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Rora mutation 1:152 RORC2 3:289e290 Rorct 1:151 RORgt 3:309, 3:312e313 Rous sarcoma virus (RSV) 2:307 RRas2 3:2 Rubella virus",
            "authors": [],
            "year": null,
            "venue": "RNase L system 4:224 ROP5 4:88 ROP16 4:87e88 ROP17 4:88 ROP18 4:88 RORa 1:152",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Sbno2 gene 2:549t A (SRA) 4:103e104 Scavenger receptor cysteine-rich (SRCR) domains 1:409 -containing proteins 1:465e466 Scavenger receptors (SRs) 1:418, 2:371e380, 2:372f, 3:85 classification and structural architecture of 2:371e374 in homeostasis and disease 2:376e377 and innate immunity 2:375e376 ligand specificity of 2",
            "authors": [],
            "year": null,
            "venue": "Salinicoccus 5:331e332 Salmonella 2:365, 2:462, 4:52e59, 5:407e409 and generation of antibody responses to 4:56e57 vaccines to infections of 4:57 Salmonella enteric 5:80e81 Salmonella typhi 1:494",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Schistosomiasis 4:150e158 cellular mediators of schistosomiasis 4:154 eggs' role in immunopathology of 4:152e153 soluble mediators of schistosomiasis 4:153e154 Schistosomiasis mekongi 5:57e58 Schwann cells 3:403 SCID mice 5:230 Scleroderma",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Scrapie 4:185t Scyphozoa 1:397e398 SDS-PAGE, for analyzing IgM 2:6 SEA mucins 2:385e386 MUC1 2:385 MUC3",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "12",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "4:293e294 aging dramatically influences prion pathogenesis within SLO 4:190e192 B cell antigen encounter and processing in spleen 3:162e163 consequences of infection on B cell encounter of antigen 3:161e162 identifying cellular sites of prion replication in 4:186e188 B and T lymphocytes 4:187 FDC-independent prion accumulation and neuroinvasion 4:188 follicular dendritic cells 4:187e188 lymph node anatomy 3:158e159 mechanisms of B cell antigen encounter in 3:159e161 neuroinvasion from, via peripheral nervous system 4:190 pathways of prion neuroinvasion from 4:191f prion accumulation in 4:186 prion infections 4:185e188 causing limited pathology in 4:188e189 stromal cells in 3:473e479 Secondary lymphoid tissues 3:428e429 migration and positioning of immune cells within 3:530e531 Secondary progressive",
            "authors": [],
            "year": null,
            "venue": "Second messenger molecules 3:25e26 Second mitochondrialederived activator of caspases (SMAC) 3:99e100 Secondary lymphoid organs (SLOs) 2:469, 3:157e162, 3:480e483, 3:493, 4:186",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "SIgA) 2:23, 2:27f, 5:7e8 antigen exclusion by 2:26e27 glycan moiety 2:25 maintenance of commensal diversity by 2:27e28 at mucosal surfaces 2:25 structural features 2:23e25",
            "authors": [
                {
                    "first": "Secretory",
                    "middle": [],
                    "last": "Iga",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "Selectins 3:505e506 expressed on blood vascular endothelium 3:512e514, 3:514t ligands 3:514t for endothelial selectins 3:506e507, 3:506f expressed on high endothelial venules 3:514e515 formation",
            "authors": [],
            "year": null,
            "venue": "SEF/IL-17R (SEFIR) 2:537 Segmented filamentous bacteria (SFB) 2:26e27",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Selective ER modulators (SERM) 5:95e96 Selective IgA deficiency 5:8e9, 5:466 Self-activated NLRP3 inflammasome 2:450 Self-antigens 2:80e81 and HLA-associated diseases 2:297, 2:299e301 presentation, for tTreg cell selection 1:270 Self-lipid antigens 2:257e258 Self-MHC molecules",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Self-pMHC complexes 1:251, 1:255, 1:257 Selfeself and selfenonself-recognition, molecular mediators",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "409--410",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Selfeself-recognition 1:407e410 sponges, grafting experiments in 1:407e409 Self-tolerance 1:268, 1:273 Self-tolerant Tcells 3:390 perspectives 1:266 thymocyteemTEC cross talk for 1:263e267 CCR7 ligand chemokines",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "CD28eCD80/CD86 costimulatory molecules in 1:265e266 CD40-CD40L",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "1:265 mTECeDC interaction 1:266 RANK-RANKL-OPG 1:264e265 TeB cross talk 1:266 thymocyteecTEC cross talk 1:266",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ltbr-Ltab",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "TNFSF cytokines in",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Semigranular cells 1:439 Seminiferous tubules",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Senescence-associated secretory phenotype (SASP)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Seronegative myasthenia gravis (SNMG) 5:168e170 Serosa 3:427 Serotype replacement 4:61 Sertoli cells 5:47e48, 5:50 Serum amyloid A (SAA) 5:114 Serum resistance-associated (sra) gene 4:102 7S",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "5:504e505 Short consensus repeats (SCRs) 1:409, 2:325e326 Short-acting b2 agonists (SABAs) 5:325e326 Short-chain fatty acids (SCFA)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Short-lived effector cells (SLECs) 3:353e354 Short-lived plasma cells",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Siamese crocodile 1:494 Sickness and health, peripheral tolerance in man in 1:88e89 Side scatter low (SSClow) cells 4:513 Side-chain binding pockets, MHCII 2:192e193 SIFD (sideroblastic anemias) 5:495te496t SIGIRR",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sialyl-Lewisx",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "409 STAT1 deficiency 4:379 STAT1 gain-of-function mutations 5:148 STAT1 loss-of-function mutations 5:411e412 STAT2 deficiency 4:379 STAT3 2:547e548, 2:547f, 2:556, 3:287e288, 3:308e309, 4:87e88, 4:408e409, 4:479, 4:529e530 IL-10 signaling that activate JAK1 and STAT3 2:547 proximal IL-10 signaling via 2:546e547 STAT3 gain-of-function mutations 5:148",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "JAK3) in 5:362f Signaling and adhesion defects 5:420e421 Signaling chemokine receptors 2:573 Signaling downstream of precursor B cell receptor (pre-BCR",
            "authors": [],
            "year": null,
            "venue": "Janus kinase family member",
            "volume": "3",
            "issn": "",
            "pages": "58--59",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Signaling lymphocytic activation molecule (SLAM) 2:415e423, 2:416f, 3:17 -associated protein (SAP) 3:202 family adapters 2:416e418, 2:418f and Tfh cell formation 3:212 and X-linked lymphoproliferative disease 2:417e418 code 2:420 distinguishing features of individual SLAM family members 2",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "2:420 perspectives on the phenotypes of SLAM family receptoredeficient mice 2:420e421 SLAM 2:419 SLAM code 2:420 SLAMF6 2:420 SLAMF7 2:420 2B4 2:419e420 salient features of 2:415t SLAM family of receptors 2:415e416 in immune regulation 2:418e419 in immunological diseases",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "Signaling mechanisms 2:461e462 gene activation pathways 2:461e462 reverse signaling 2:462 triggering caspase function independently of gene activation 2:461 triggering functions of RIPK3 and MLKL independently of gene",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Signalosome 3:45e46, 5:391 Signal-strength model",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Simian immunodeficiency virus (SIV) 4:238 and Bcell dysfunction 3:222e223 Simultaneous pancreas-kidney (SPK) transplant",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Sindbis virus (SINV) 4:334",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "319--320",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Single CD62L + central memory T (TCM) cells 3:387e388 Single epitope-specific T",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Sos1, and thymocyte selection 1:245 SOX2 4:422 Sox17 transcription factor 1:9e10 Sp185/333",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Spaetzle-processing enzyme (SPE) 1:458 Spare respiratory capacity (SRC) 3:42 Specialized secondary lymphoid organs (SLOs",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Specific antibody deficiency (SPAD) 5:467 Spectrin-b2",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Spermatogenesis 5:46e47, 5:47f, 5:49e50 Sphingomonas",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "195e197 Staphylococcus aureus enterotoxin B (SEB) 5:310 Staphylococcus epidermidis 1:494 Staphylococcus sciuri 5:331e332 Stealth virus 5:17e18 Stem cell factor (SCF) 5:276 Stem cell factor (SCF)/cKit feedback mechanism",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "Stem cell gene therapy 5:490e491 Stem cells/bone marrow transplant infusion 5:517 Stemness 4:420e421 -associated antigens 4:421 vaccines targeting 4:423 rationale for targeting 4:421 STEP 4:349e350 Sterile a motif (SAM) 3:11 Steroid 21-hydroxylase 2:169e170 Steroid hormones 5:75fe76f in female reproduction 5:78e81 immune privilege of pregnant uterus 5:80e81, 5:80f immunocompetence of cycling female and window of vulnerability 5:78e79 Steroids 5:307e308 Sterol regulatory element-binding protein",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "StevenseJohnson syndrome (SJS) 1:145 and HLA 2:310, 2:313e314 STIM1 deficiency 5:394e395 STING associated vasculopathy with onset in infancy (SAVI) 5:495te496t, 5:500 STING-associated vasculopathy 5:145 Stochastic competition model",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "Stochastic variation 3:387e388 Store-operated calcium entry (SOCE) 3:27 defects in 5:394e395 MAGT1 deficiency 5:395 ORAI deficiency 5:394 STIM1 deficiency 5:394e395 Stratum corneum (SC) 3:443e444, 5:193e195, 5:193b Stratum granulosum 5:194 Stratum spinosum 5:195",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF115": {
            "ref_id": "b115",
            "title": "Streptococcus pyogenes",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "See Ischemic stroke Stromal cells 3:402 basic function of 3:473e474 in secondary lymphoid organs 3:473e479 in analgen 3:477 antigen transport 3:475, 3:477 CXCL12-producing reticular cell 3:475e476 3:474t mucosal-associated lymphoid tissue 3:473, 3:475 in organ-specific tissue structures 3:476 pericytes and vascular smooth muscle cells 3:476e477 T cell zone reticular cell 3:475 tissue microenvironment",
            "authors": [],
            "year": null,
            "venue": "Stress-induced self-ligands 1:354e355 Stroke",
            "volume": "3",
            "issn": "",
            "pages": "27--29",
            "other_ids": {}
        },
        "BIBREF117": {
            "ref_id": "b117",
            "title": "Stromal-derived factor-1a (SDF-1a) 3:402 Strongylocentrotus droebachiensis 1:462e463 Strongylocentrotus intermedius 1:462e463 Strongylocentrotus purpuratus 1:463e464 Strongyloides stercoralis 1:340e341 Strongyloides venezuelensis 1:327e328 Subcapsular sinuses (SCS) 3:158",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF118": {
            "ref_id": "b118",
            "title": "Subcutaneous administration of IgG (SCIG) 5:517e518 Subcutaneous allergen immunotherapy (SCIT)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "Subcutaneous immunotherapy (SCIT) 5:313e314 Subepithelial dome 5:3e4 Suberites domuncula 1:407, 1:409e414 Sublineage cTEC-and mTEC-restricted progenitors 1:170, 1:173e174 Sublingual immunotherapy (SLIT) 5:313e314 Submucosa",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF120": {
            "ref_id": "b120",
            "title": "SEBOV) 4:355 Sulfamethoxazole hypersensitivity 2:312 3-Sulfated galactosylceramide 1:357e358 Sulfatide-loaded human CD1 tetramers 2:80 Sulfoglycolipids",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sudan Ebolavirus",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF122": {
            "ref_id": "b122",
            "title": "Superoxidase dismutase (SOD) 1:424 Supported lipid bilayer (SLB) methods 3:17 Suppressor of cytokine signaling (SOCS)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Surface plasmon resonance (SPR) 2:405, 3:2e3 Surfactant proteins 1:539 Surra 4:102 U Ubc13 2:134e135 Ubiquitin",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "Ubiquitin ligase (E3) 4:237e238 Ubiquitin signaling to NF-kB 3:51e64 Ubiquitin-activating enzyme (E1) 4:237e238 Ubiquitination 2:242e243, 4:237e238, 4:237f Ubiquitin-conjugating enzyme (E2) 4:237e238 Ubiquitin-specific proteases (USPs) 3:51, 3:60 UDP-glucose:glycoprotein glucosyltransferase (UGGT) 2:233e234, 2:237e238 UL16-binding proteins",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "UNG) 2:126, 5:479e480 deficiency 5:482 Uric acid 5:252 Urinary tract infections",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Uracil N-Glycosylase",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "usefulness of immunization on",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "Urodelean adaptive immunity",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF128": {
            "ref_id": "b128",
            "title": "Urticaria (hives) 5:337t Urticaria",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF130": {
            "ref_id": "b130",
            "title": "and IgM",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF131": {
            "ref_id": "b131",
            "title": "Waldeyer's ring 1:136, 3:420e421, 3:421f",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF135": {
            "ref_id": "b135",
            "title": "WAT) 5:37 immunology of 5:37e38 White spot syndrome virus (WSSV) 1:444 Whole cell vaccines 4:544e545 Wilms tumor 1 (WT1) 4:421 Winged helix 5:354e356 deficiency (WHD) 5:350e359 factor 5:350 WiskotteAldrich syndrome (WAS) 3:88e89, 4:377, 5:416e419, 5:417t, 5:518 actin cytoskeletal restructuring by WASp 5:416e418 interacting protein (WIP) deficiency 5:417t, 5:420 migration defects in 5:418e419 DC migration 5:418e419 establishment of hematopoietic system in bone marrow 5:418 lymphocyte migration 5:419 phagocytic cell migration 5:418 symptoms, discovery, and genetics",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "4--5",
            "other_ids": {}
        },
        "BIBREF136": {
            "ref_id": "b136",
            "title": "Wnt/b-catenin signaling pathway 4:402 Wolbachia 4:3e4 Work-shop cluster 1 (WC1) 1:535 Worm parasites 4:167 Wound healing 2:557e559 WSX-1/TCCR expression 3:288e289 Wuchereria",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF137": {
            "ref_id": "b137",
            "title": "X-box-binding protein 1 (XBP1) 1:113, 3:202e203 and plasma cell differentiation 3:210e211 X-CGD carriers, manifestations of 5:488 X-chromosome (Xq13) 5:361 XCL1 1:349, 4:435e436 XCR1 2:576e577 XCR1 + DCs 4:215e216 Xenograft",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF138": {
            "ref_id": "b138",
            "title": "Xenopus 1:475e476, 1:486e487 hemangioblasts in",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF139": {
            "ref_id": "b139",
            "title": "Xenopus laevis 1:486",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "490--491",
            "other_ids": {}
        },
        "BIBREF141": {
            "ref_id": "b141",
            "title": "Xenopus tropicalis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF142": {
            "ref_id": "b142",
            "title": "420 Xerosis 3:443 causes of 3:444t X-linked agammaglobulinemia (XLA) 3:48, 3:208, 4:376, 5:461 X-linked CSR-D 5:480e481 X-linked immunodeficiency (XID) with magnesium",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF143": {
            "ref_id": "b143",
            "title": "X-linked inheritance 5:416 X-linked inhibitor of apoptosis (XIAP) 2:418 X-linked lymphoproliferative disease 2:417e418 type 1 (XLP1) 4:380, 5:433 type 2 (XLP2) 4:380e381 X-linked neutropenia (XLN) 5:416e417, 5:417t",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF144": {
            "ref_id": "b144",
            "title": "X-linked severe combined immunodeficiency (SCIDX-1; XSCID) 1:192, 2:509e510, 5:360e363 clinical presentation and diagnosis 5:360e362 gene therapy 5:363e364 treatment 5:362e363 X-linked syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF145": {
            "ref_id": "b145",
            "title": "5:373e374 XRCC4/ligase IV 2:139 and DSB ligation 2:110e111 XRCC4-like factor (XLF) and DSB ligation 2:110e111 redundancy, in V(D)J recombination 2:111e112 Y Y132 3:11 Y446C mutation 5:432 Yaa mutation 5:137 Yamanaka factors (SOX2 and OCT4) 4:420e421 Yellow fever virus",
            "authors": [],
            "year": null,
            "venue": "X-linked thrombocytopenia (XLT) 5:416, 5:418 X-ray crystallography 5:285 XRCC4 2:139e140",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF146": {
            "ref_id": "b146",
            "title": "Yersinia enterocolitica antigens 1:87e88 Yersinia pestis 4:70e72, 4:256e257 dissemination of to dLN and bubo development 4:71e72 dissemination to dLN and bubo development 4:71e72 flea transmission and plague pathogenesis 4:70e71 and phagocyte, interactions in the skin 4:71 dendritic cells 4:71 macrophages 4:71 neutrophils",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF147": {
            "ref_id": "b147",
            "title": "Yolk sac (YS) 1:1e2, 1:2f, 1:47 Yolk sac/fetal liver precursors 2:544e545 YY1 1:66 Z Zaire ebolavirus (ZEBOV)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF150": {
            "ref_id": "b150",
            "title": "Zebrafish PGLYRP5 (PGRP-SC) 2:395e396 z chain-based receptors for antigen 4:562e563 Zfp36 2:549t Zidovudine",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "348--349",
            "other_ids": {}
        },
        "BIBREF151": {
            "ref_id": "b151",
            "title": "Ziehl-Neilson staining method 4:26 Zinc-a2-glycoprotein (ZAG) 2:274e275, 2:275f Zip code 3:336e337 Ziv-aflibercept 4:551t ZMAPP 4:360 ZnT8 autoimmunity",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF152": {
            "ref_id": "b152",
            "title": "TCRgd activation 2:79 Zonula occludens-1 (ZO-1) 3:522 Zooxanthellae",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Zoledronate",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "1",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "repair pathway choice in 2:139f generation of 2:126 domain antibodies 4:555 donor-specific antibodies 5:268, 5:506 durability of responses 4systemic lupus erythematosus 5:207 targeting cancer 4:550e556 approved antibodies 4:550e552 clinical trials 4:552e553 identification and molecular engineering of therapeutic antibodies 4:554e555",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "lymphoid organs and 3:180 in mammals 1:132 perspectives on purpose of 3:183 plasma cell development in 3:202 reaction 1:111e112, 3:181e182 reactions, against TI antigens 3:228 route of differentiation, of B cells 3:209e210, 3:210f Germinal center B cells (GC B cells) 3:181e182, 3:270, 3:530e531 Germinal center dark zone (GC DZ) 3:181e182 Germinal center light zone (GC LZ) 3:181 Germinal centers (GC), appearance of 14:84e85 Glutathione S-transferase (GST) 4:169 Gluten 5:219 adaptive immune responses to GPR183. See EBI2 G-protein 3:84 heterotrimeric in chemokine receptor signaling 3:67 functions of 3:67 G-protein receptor kinases (GRKs) 3:65e66 G-protein regulatory (GPR) proteins 3:65e66 G-protein signaling 3:65e66 atypical chemokine receptors and 2:581 G-proteinecoupled receptors (GPCRs) dysfunction, predictors of 5:267e268 Graft rejection, and class I MHC molecules 2:174e175 Graft-versus-host disease (GvHD) treatment 5:516e517 Graft-versus-host (GvH) reactions 5:241 Graft-versus-leukemia (GvL) 4:560, 5:241e242 Gram-negative bacteria 1:411e412 anti-CPS responses 3:232 CPS expression of 3:231 Gram-positive bacteria 1:412 anti-CPS responses 3:232 CPS expression of 3:231",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "features of 3:134e136 Jak protein tyrosine kinases 3:136e138 receptor families and shared subunits 3:136 specificity 3:139e140 contributions to and from the chromatin landscape 3:139e140 intracellular cofactors 3:139 suppressors of cytokine signaling (SOCS) 3:138e139 transcriptional regulators 3:138 Japanese encephalitis virus, vaccine for 4:390t Jawed vertebrates (gnathostomes) 1:468 Jawless vertebrates (agnathans) 1:468 adaptive immunity in 2:148e152 TCRgd conversation of 2:78 See also Agnathans, immune system of Jejunal Peyer's patches (JPP). See Peyer's patches (PPs) 'Jennerian' vaccines 4:389 Jeotgalicoccus 5:331e332 JMJD2A 2:137e138 John Cunningham virus (JCV) 5:185 Jun N-terminal kinase (JNK) idiopathic arthritis (JIA) 5:212e214, 5:214t, 5:217 Juvenile myelomonocytic leukemia (JMML) 5:433 Juvenile thyroiditis 5:151t Juxtamembrane domain (JMD) 2:586",
            "latex": null,
            "type": "figure"
        },
        "TABREF7": {
            "text": "Danger receptors (DNGR-1) 1:349 Danger-associated molecular patterns (DAMPs). See Damage-associated molecular patterns (DAMPs) DAP-12 (DNAX activation protein of 12 kDa) 1:371 Dapsone 5:515 DAP-type peptidoglycan 2:397e398 DARTs (dual affinity retargeting) 4:556e557 Daughter cells 3:387e388 DAVID (deficient anterior pituitary with variable immune deficiency) syndrome 5:473e474 DBLs (Duffy-binding like proteins) 4:95 DCIR 4:546 DCLRE1C (Artemis) 5:373 DC-SIGN 4:546 DE3 enhancer element, and TRA gene 2:93 DE4 enhancer element, and TRA gene 2:93 dermal. See Dermal dendritic cells (dDCs) discovery of 1:345 FDCs. See Follicular dendritic cells (FDCs) functionally incompetent 4:501 functions 2:408 GM-CSF-driven differentiation of 5:99 DNA ligase IV 5:373 DNA looping 2:60 DNA methyltransferase-1 (DNMT-1) 1:40 DNA mismatch repair. See mismatch repair DNA vaccination/vaccines 1:527, 4:546 DNA-binding domain (DBD) 5:384 DNA-dependent protein kinase (DNA-PK) holoenzyme DNA-PKcs 2:139e140, 5:372e373 DNA-PKcs/Artemis complex 2:109e110 and V(D)J recombination 2:109, 2:112 E E proteins 1:151, 1:238e239, 1:381e382 in gd T Cell Development 1:214 E2A 1:48e49, 1:64, 1:66, 1:68 Early T cell development, control of ab and gd T cell receptors 1:234e236 differences in TCR signals that specify ab and gd fates 1:237e239 gd TCR and commitment to gd T cell lineage 1:237 gd TCR and effector fate specification 1:239 by notch and T cell receptor signals 1:234e241 pre-TCR and b-selection checkpoint 1:237 pre-TCR and gd TCR characteristics 1:237 T cells development in thymus 1:236e237 Early T cell precursors [progenitors] (ETPs) Ectopic lymphoid organs. See Tertiary lymphoid organs (TLOs) Ectopic lymphoid structures. See Tertiary lymphoid organs (TLOs) Ectopic lymphoid tissues, stromal cells in lymphocyte homing cascade 3:494e495natural killer T (NKT) cells 3:498e499 in non-lymphoid organs 3:495e498 to and within non-lymphoid tissues 3:493e504 random migration 3:496, 3:498 role of chemotactic cues and antigen presentation in 3:496e498 role of ECM and other structural elements survival, apoptosis, and clearance 1:339 and mast cell survival and histamine release 1:340 and microbes and viruses 1:340e341 mouse eosinophils, unique features of 1:337 mouse strains for manipulating 1:337t T cells, interaction with 1:339e340 unifying hypothesis 1:342 and viruses and antiviral vaccines Epithelial defenses in the midgut 1:456fEpithelial lining fluid and surfactant 5:295",
            "latex": null,
            "type": "table"
        },
        "TABREF18": {
            "text": "of brain 5:54e56 cytolysis and cytokine production 4:246 and cytomegalovirus infections 4:257 cytotoxicity 1:353e355 defect in GATA2 expression and 4:243 deficiencies 4:378e379 development of 1:141e142 discovery and identification of 1:353 dynamic regulation of 1:370f effectors of innate immunity against cancer and infection 4:487e488, 4:488f female reproductive tract 5:66 functional NK cell deficiency 4:379 functional subsets 1:369e370 functions 2:406e408 as healthy donors of CD56 1:369e370 in HIV-1 infection 4:262e269 in host defense and transplantation innate and adaptive immunity of 1:369 KIR + NK cells 4:263e266 in liver 5:14 in lung 3:455t major histocompatibility complex 2:171 maturation of 1:142e143 ILC1 development 1:143 NK1.1 5:41 NKG2C + 4:249 NKG2D-mediated recognition by 4:266 origins and localization of 1:353 proinflammatory and immunosuppressive cytokines 1:369 receptors 1:371, 1:533e534, 4:254e255 recognition 1:354e355 regulating T cell responses in vivo 4:256e257 cytotoxicity 4:256 inhibitory cytokine production 4:256e257 regulation of activation 4:488e489 response to viral challenge 4:244e245, 4:245f surveillance for missing self 1:354 in swine 1:540e541 and T cell regulation of viral persistence 4:257e258 human infections, genetic studies in 4:257e258 therapeutic depletion of NK cells and LCMV infection 4:257 T celledependent viral pathogenesis, influence of NK cells on 4:255e256 TI antibody response of 3:231 trafficking 1:353 transcriptional control of early NK cell 1:143e146 ETS family transcription factors 1:145e146 ID2 1:144e145NFIL3 1:145 T-box binding proteins 1:143e144 TOX1 1:145 viral immune evasion and 4:247f viral recognition and 4:244f, 4:246e247 Natural killer complex (NKC) 1:508 Natural killer receptors 1:508 Natural killer T (NKT) cells 1:195, 2:536, interaction of NKT cells with each other and other regulatory cells in tumor immunity 4:464e466 type I NKT cells 4:461e463, 4:462f type II NKT cells 4:463e465, 4:465f type I NKT cells 1:218 Natural killeremediated killing 4:77 Natural regulatory cells (Bregs). See Regulatory B cells (Bregs) Natural suppressor cells 4:513 Natural Tregs (nTregs) 4:452e453 Naturally occurring antibodies (NAbs) Ocular immunity 5:24, 5:26e27 Ocular MG (OMG) 5:169e170 Oculina patagonica 1:401 Odocoileus hemionus 4:186 Ofatumumab (OFA) 2:323, 4:550e551, 4:551t Okadaic acid 1:414 Old friends hypothesis 4:167e168, 5:332 Oral allergy syndrome (OAS) 5:284 Oral immunotherapy (OIT) 5:313e314 Orchestrating tissue remodeling 4:406 Orchitis 5:50e51 autoimmune orchitis and antisperm antibodies 5:51 infectious 5:51 Order Lagomorpha 1:515e516 Oregon coast 1:402e403 ORF74 protein 4:273 Organ transplantation. See Transplantation immunology Organized lymphoid tissue in the respiratory tract 3:459e460 bronchus-associated lymphoid tissue (BALT) 3:460 larynx-associated lymphoid tissue (LALT) 3:460 nose-associated lymphoid tissue (NALT) 3:459e460 Organogenesis 1:171e173 stages of 1:171 Oropharyngeal candidiasis (OPC) 2:536 Orphan granzymes 3:368 Orta-gonad-mesonephros 1:105e106 Oryctolagus cuniculus 1:515e516 Oryctolagus cuniculus algirus 1:515e516 Oryctolagus cuniculus cuniculus 1:515e516 Pacifastacus leniusculus 1:440, 1:442e443 Paclitaxel 4:496, 4:519te520t, 4:571, 4:573 Paired box protein 5 (PAX5) 1:113 Pam3CyseSere(Lys)4 1:411 Pamidronate, and TCRgd activation 2:79 B cell anergy in humans 1:88e89 central and peripheral tolerance mechanisms 1:84 in man in sickness and health 1:88e89 mechanism of 1:84e87 B cell anergy 1:84e87 clonal ignorance 1:87 lack of T cell help and regulatory T cells 1:87 survival factors, competition for 1:87 mechanisms of 1:85f peripheral tolerance to de novo-generated autoreactive B cells 1:89 Peripheral blood mononuclear cells (PBMCs) Peripheral prion exposure, routes of 4:186f Peripheral regulatory T cells (Tregs) 3:320 Pertussis toxin (PTX) ADP ribosylates 3:67 Peyer's patches (PPs) 1:130, 1:136, flagellin perception by FLS2 1:390e391 pattern recognition receptors (PRRs) 1:390 systemic immunity 1:392e393 Plasma, negative immune modulators in 5:104 Plasma cells (effector B cells) 1:113, 1:124, Plasmodium malariae 4:89e90, 4:94 Plasmodium ovale 4:94 Plasmodium vivax 4:89, 4:94 Plasticity of neutrophils 1:286 Platelet activating factor (PAF) 1:338e339 Platelet/endothelial cell adhesion molecule-1 with absence of B and T lymphocytes 5:369e377 biochemical pathways affected in 5:362f combined T cell and B cell deficiency 5:360e368 cytokine receptors 5:361, 5:363e364 diagnosis of 5:513 hematopoietic stem cell transplantation (HCT) 5:362e365 HSCT and risk of GVHD 5:513 IL-7 signaling 5:361e362 IL-7Ra-deficient SCID 5:364e365 PKCq, NFkB, and AP-1 pathways 3:31 porcine, cluster of differentiation markers on 1:543t priming 3:336e337 regulation 5:187 regulatory. See Regulatory T cells (Tregs) release of calcium storage from ER 3:26e27 resident memory T lymphocytes 5:30, 5:32 responses to virus infections 4:318e323 restimulation of 3:385 second messenger molecules 3:25e26 severe combined immune deficiency with absence 5:369e377 signal duration and lineage choice 1:226 signal strength and lineage choice 1:226 signal transducer and activator of transcription in 4:229e230 signaling 1:226 single T cell adoptive transfer 3:385e387, 3:386f single T cell fate mapping in vivo 3:385e387, 3:386f single T cell-derived immune responses 3:387e388 skin-infiltrative T cells 3:447 especific promoters 2:85e86 surveillance in barrier tissues 3:344e345, 3:345f swine 1:542e543 systemic lupus erythematosus 5:207 thymus-derived 1:498 tissue homing and accumulation in nonlymphoid tissues 3:336e337 tissue-specific trafficking of 3:491f tolerance, MDSCs 4:529e530 transfer 4:570 treatment data 5:185e186 tuning effector functions 3:338 virus-specific 4:560e562 T follicular helper (Tfh) cells 3:177, T lymphocytes. See T cells T regulatory cells. See Regulatory T cells (Tregs) T1 B cells 1:101 T2 B cells 1:101 T2-MZP Bregs 4:478, 4:480 T2-MZP CD21HighCD19 + Bregs 4:479 T2-MZPs 3:271e272 T3SS effectors, proinflammatory 4:46 T10/T22 2:271 Tabalumab 3:265 TACI (transmembrane activator and calcium Taenia, experimental models of 4:163 Taenia solium 4:4e5, 4:160, 4:163, 4:181 Tai Forest (Cote d'Ivoire) ebolavirus (CIEBOV) Tandem repeats (TRs) 2:381 Tapasin 1:483, 2:168e169, 2:280 enhancement of peptide selection by MHC I by 2:236 structure 2:235e236 TapasineERp57 conjugate 2:236 Targeted therapies and immunotherapy, combination of 4:574e576 Tartrate-resistant acid phosphatase (TRAP) 5:145 Tasmanian devil (Sarcophilus harrisii) 1:504 TeB cooperation 1:266, 5:480e481 TeBeNK + severe combined immune deficiency (TeBeNK + SCIDs) T-box binding proteins 1:143e144 T-box expressed in T cells (T-bet) 1:160, TCF-1 1:152 Tcf7 gene 1:152 Tcfe2a 1:38e41 TCRa gene 1:476 TCRm + T cells 1:505 TCRab receptors germ line TCR gene segments for 2:77t TCRb gene 1:476 TCR:antigen ligand interaction 4:436 TCR/CD3 complex, defects in 5:392e393 germ line TCR gene segments for 2:77t murine TCRgd ligands 2:81e82 MHC-related 2:81e82 recognition of lipids presented by CD1 2:80 stimulation of human Vg9Vd2 T cells by phosphoantigens 2:79 structure and diversity 2:76e77, 2:77f V segment used by 2:77e78 Vg9Vd2 TCR recognition by phosphoantigens 2:80 TCRgd T cell responses 5:222 TCR:MHC/p interactions 4:434 TCR-rearrangement excision circles (TREC) 5:244 T-dependent antigens, and IgM production 2:9 T-dependent responses generation of long-lived plasma cells during 3:195e196 MZ B cells as antigen cargo during 3:221e222, 3:222f Teleosts 1:481 adaptive immunity 1:484e485 antibody development and production 1:484e485 innate immunity 1:482 lineage 1:481 locations of immune organs in 1:482f MHC genes 1:483 poikilothermic (cold-blooded) 1:483e484 Telomerase 4:423 Telomerase Cajal body protein 1 (TCAB1) 5:454 Telomerase RNA component (TERC) 5:454 predisposition to the development of tumors 3:483 prions 3:483 protection from pathogen dispersal 3:483 regulation of 3:483 Tertiary lymphoid tissues. See Tertiary lymphoid organs (TLOs) Testicular immune privilege 5:46e53 features of 5:46e47 innate defense mechanisms of testis-specific cells 5:49e50 Leydig cells 5:50 male germ cells 5:50 myoid peritubular cells 5:50 Sertoli cells 5:50 mechanisms underlying 5:47e49 Tetanus toxin C fragment (TTCF) 2:243 Tetherin 4:200, 4:224 Tethering/rolling 3:486e487 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) differentiation 3:287e290, 3:288f effector functions of classic 3:291 IFNg production 3:288e290 involvement in diseases 3:291 origins of 3:289e290 role of epigenetics in regulation 3:290 in skin 3:447 Th1 cells response in acquired specific resistance 4:29e30 Th1 cytokines 4:529e530, 5:87, 5:244 Th1 response 4:144 Th1/IL-35 cluster 2:530 Th1/M1 phenotype 4:411 Th1-polarized effectors 4:293e294 Th1/Th17 cluster 2:530, 4:45 Th2 1:326, 1:336, 4:152, 5:429 Th2 cells 1:383, 2:494, 2:519e520, 3:269, Th2 cytokines 4:529e530, 5:244 Th2 cytokines, functions of 3:297 Th2 disease 1:384 Th2 response 5:298, 5:340 Th2/M2 phenotype 4:411 Th2-promoting innate lymphoid cells 5:298 host defense and 3:311e312 identification of 3:307 immunological effects of 3:309e310 multifunctionality of 3:310e311 plasticity of 3:311 in skin 3:447 subset 5:207 therapeutic potential 3:312 transcriptional regulation of 3:308e309 Th17 response 5:297, 5:299 Th22 cells 3:312e313 cell differentiation and function 3:313f in skin 3:447 ThCTL 4:293e294 in tumor immunity 4:444e446 and antitumor antibody responses 4:444 and antitumor CD8 cytotoxic T cell response 4:444e445 as antitumor effector cells 4:445e446 Therapeutic cancer vaccines 4:570 Therapeutic monoclonal antibodies (mAbs) 4:570 Thimet oligopeptidases (TOP) 2:229 Thioester-containing proteins (TEPs) 1:427, 1:459 ThPOK (T helper-inducing POZ Kr\u00fcppel) in CD4 commitment 1:229 on gene expression 1:230e231 silencer 1:229e230 TCR signaling, role of 1:229 3' regulatory region (RR) 2:60 Thrombin 2:340 Thrombin-activatable fibrinolysis inhibitor (TAFI) 2:341 Thrombocytes 1:499 Thrombomodulin 2:340e341 Thrombopoietin 3:127 Thrombotic microangiopathy 2:329 Thy-1 T cell marker 4:27 Thymic cortex 1:169 TIR8. See IL-1R8, signaling adaptors with TIR-domain-containing adaptor protein inducing interferon-b (TRIF) 3:109 TIR-mediated immunity 5:410e411 Tissue factor (TF) 2:338e339 Tissue inhibitors of metalloproteinases (TIMPs) 4:145e146 Tissue injury, immune response of CNS to 3:470e471 Tissue macrophages 1:306, 2:544e545 Tissue plasminogen activator (tPA) 2:341 Tissue transglutaminase (TT) 2:170 Tissue transplantation 1:530 Tissue tropism 3:330 Tissue-associated microbial communities in Hydra 1:401e402 Tissue-draining interstitial fluid 1:302e303 Tissue-resident dendritic cells 3:330 Tissue-resident memory T (TRM) cells 3:340, local immune response by 3:348e349 pathogenic responses 3:350 role in health and disease 3:349e350, 3:349f role of infection, inflammation, and local cytokines in 3:348 Tissue-restricted antigens (TRAs) 1:170, 1:264, 3:395 models of negative thymocyte selection 1:246 Tissue-specific antigen (TSA) genes 5:436e437 Tissue-specific imprinting 3:345e346 Tissue-specific lymphocyte recirculation 3:490e491 Tissue-specific processes 4:406 Tissue-specific trafficking of T cells 3:491f TNF-and iNOS-producing (TiP) DCs 1:350 TNF gene 2:457e458 TNF-like ligand 1A (TL1A) 1:383 Tob-1 3:289e290 Tobacco mosaic virus (TMV) 1:392e393 Tocopherol. See Vitamin E Tofacitinib 5:216 Tolerance 2:566e567, 5:270, 5:273 versus activation in liver 5:15e16 antigen presentation by tolerogenic APCs 5:15 break of hepatic tolerance and activation of T cells 5:15 elimination of effector T cells 5:15e16 tolerance via immune regulatory cytokines and molecules 5:15 induction 1:257e258 to self 5:242 transplant 5:257e258 Tolerance, central 1:78e82 B cell development 1:78 B cell positive selection 1:78 central B cell tolerance research, history of 1:79e81 clonal deletion 1:79 defects in disease 1:79 definition 1:78 negative selection, sensitivity of 1:79 receptor editing 1:78e79 extent of 1:79 Tolerogenic dendritic cells 3:154e155 Toll pathway 1:458e459 Tolleinterleukin-1 receptor (TIR) domain 1:398e399 Toll-like receptors (TLRs) 1:93, 1:100, 1:108, and allergic airway disease 5:297 for antigen signal 4:226 -induced IL-12 4:125e126 of keratinocytes 3:444e445 ligands 1:87, 3:269e271, 4:479, 5:31 and TI antibody response 3:230 pathways 4:291 role in antifungal immunity 4:77e78 signaling 1:123, 2:545, 3:57e58 IL-1R and 3:54e56 signaling, and MZ B cell development 3:220 TLR1 4:545 TLR2 4:202, 4:545, 5:337 TLR3 1:349, 4:202e203, 4:545, 5:50, 5:407 TLR4 1:295, 1:482, 2:546e547, 4:53e54, TLR4 ligand 4:573e574 TLR6 1:482 TLR7 1:339, 4:202, 4:545 TLR8 4:202, 4:545 TLR9 1:114e115, 2:485e486, 4:202, 4:545 Toll-like receptors (TLRs) and IL-1 family receptors 3:106e114, 3:108t, 3:109f MyD88 proinflammatory signaling pathway downstream of 3:110e111 and TRIF signaling for induction of type 1 interferons 3:111e112 negative regulators of 3:112e113 signaling adaptors with TIR domains 3:109e110 structural features of 3:108e109 Tollreceptor-related 2 (HyTRR-2) 1:398e399 Tonic B cell receptor signaling 2:48 Tonsilla pharyngea 3:420e421 Tonsilla tubaria 3:420e421 Tonsillae palatinae 3:421 Tonsillar antibody-producing B cells 3:424 Tonsillar immune reactions 3:425 Tonsillar intraepithelial lymphocytes 3:424 Tonsils 1:345, 3:420e426, 3:473, 5:227 adenoids as NALT 3:424e425 embryology and life cycle of 3:421e423 functional histology of 3:423e424 immunoglobulins, secretion of 3:424 intraepithelial lymphocytes and innate lymphoid cells 3:424 local tonsillar immune reactions 3:425 vascular supply and lymphatic drainage of 3:421 Waldeyer's ring 3:420e421 Toso/Faim3. See Fcm Toxic epidermal necrolysis (TEN). See antimicrobial activities of IFNg 4:126e127 brain infection 3:496 development of protective immunity 4:125e126 host protective mechanisms to control intracellular Toxoplasma gondii 4:126f immune evasion mechanisms used by 4:128f immune protection and evasion 4:125e132 immunoregulation 4:128e129 interference with host cell signaling 4:127 Toxoplasmic encephalitis (TE) 4:125 TPP1 5:454 TR B cell selection, B cell-activating factor and 1:95 Tr1 cells 5:316, 5:445 Trachea 3:453 Trachemys scripta 1:495 TRA/D gene 2:91e94 cis-regulatory regions in TRA locus 2:91e93 cis-regulatory regions in TRD locus 2:93 general organization 2:91 locus 2:92f V(D)J recombination at TRA/D locus TNFR1 recruits receptor-interacting protein (RIP) 3:118 Tumor necrosis factor receptor superfamily (TNFRSF) 3:116, 3:394 generalized signaling pathways 3:118f mutations in 5:467e469 signaling pathways used by death domainecontaining members of TNFRSF 3:120 TNFRSF-1a 5:426 TNFRSF-6 5:426 TNFRSF-10a 5:426 TNFRSF-10b 5:426 TNFRSF-12 5:426 TNFRSF12A, synthesis of 2:458 TNFRSF-13B 5:467e468 TNFRSF-13C 5:467 TNFRSF-23 5:426 TNFSF cytokines in thymocyteemTEC cross talk 1:264e265 TNFSF10 (TRAIL) 2:458 TNFSF11 (RANKL) 2:458, 2:461 TNFSF13B (BAFF) 2:458 TNFSF15 (TL1A) 2:458 TRAF-mediated pathways 3:116e120 additional kinases activated by TNFRSF receptors 3:119e120 additional transcriptional pathways regulated by TNFRSF receptors 3:119 context dependency of 3:120e121 NF-kB1 3:116e118 NF-kB2 3:118 Tumor necrosis factor receptor-associated periodic syndrome 5:495te496t, 5:500 treatment of 5:501e502 Tumor necrosis factor superfamily (TNFSF) cytokines 1:264 in thymocyteemTEC cross talk 1:264e265 death by 1:295e296 TNFSF10 (TRAIL) 2:458 TNFSF11 (RANKL) 2:458, 2:461 TNFSF13B (BAFF) 2:458 TNFSF15 (TL1A) 2:458 Tumor progression locus (TPL)-2 kinase 2:457e458 Tumor targeting, of MHC-I and APPM matrix remodeling and tumor cell invasion 4:494e495 tumor cell survival and proliferation 4:494 therapeutic strategies to target 4:496e497 Tumor-derived colony-stimulating factors 4:528 Tumor-infiltrating B cells 4:470 Tumor-infiltrating dendritic cells (TIDCs) Tumor-reactive CD8 T cells 4:436e437 Tumor-specific antigens (TSAs) 4:399, 4:447 Tunicamycin 2:3e4 Turner's syndrome 5:97, 5:152 TWEAK 2:458e460 mutation 5:468e469 12/23 rule of V(D)J recombination 2:85e86, 2:99, 2:102 22q.11 deletion syndrome 5:351e352 Twist 4:422e423 2B4 2:419e420 Two-dimensional affinity 3:17e18 Type 1 diabetes. See Diabetes, type 1 Type 2 diabetes. See Diabetes, type 2 Type 2 immunity 1:385 Type 2 inflammation 3:297e298, 5:306, 5:308e309in the mediation of CRSwNP 5:309f sensitization 5:307 Type 2 innate lymphoid cells (ILC2) 5:317 Type I NKT cells (iNKTs) 1:218e219 activation of 1:219 cell development 1:219e220 deficiency 1:221 Egr2 activation 1:219e220 ether-bonded lipids and 1:219 heterogeneity of 1:220 Id2 and Id3 gene expression 1:221 semi-invariant TCR in 1:219 Type III secretion system (T3SS) 4:43e44 Type-1 immature-transitional (T1) B cells 3:220 Type-2 immature-transitional (T2) B cells 3:220 Typhimurium 4:54e55 Typhoid, immune response during 4:55f Typical and atypical chemokine receptors and 2:579 Tyro 3, Axl and Mer (TAM) signaling 5:48 Tyrophagus putrescentiae 5:282 Tyrosinase-related protein 1 (Trp1) epitope 4:445e446 Tyrosine kinases and phosphatases, defects in 5:393e394 generating an optimal T cell response using 4:537e539 bypassing immune suppressive signals within TME 4:538e539 vaccines with potency 4:537e538 to induce CD4 T cell memory 4:297e298 -induced dendritic cells prime CD8 + T cells sex differences in T cell responses to 5:87e88 targeting stemness-associated or CSC-associatedgenes 4:423 See also Viral vaccines Vaccinia virus (VACV) 2:598e599, 4:288 rabbitpox mutant 4:274 Vaginal microbiome 5:63e65 Vancomycin 4:61 Vanishing bile duct syndromes (VBDS) 1:296 var2csa 4:97 Variable domain 2:17e18 Variable leucine-rich repeat (VLR) proteins 3:325 Variable lymphocyte receptors (VLRs) 1:468, 2:148e152 agnathan immune response 2:151 generation of diversity in VLR genes 2:148e150 mature VLR genes and proteins 2:150 VLR repertoires and antigen binding 2:150e151 Variable regions 2:126, 2:130e131 error-prone BER in the first phase of 2:127e128 error-prone MMR in the second phase of 2:128e130 somatic hypermutation in 2:127f Variant Creutzfeldt-Jakob disease(vCJD) -mediated signaling 1:340 Vascular endothelial cadherin (VE-cadherin) 3:517, 3:522 Vascular endothelial cells 1:169 Vascular endothelial growth factor (VEGF) ATM-dependent DSB response and redundancy with XLF in 2:111e112 cleavage reaction 2:103f C-NHEJ 2:107e111, 2:108f DSB recognition 2:108e109 end processing 2:109e110, 2:110f ligation 2:110e111 role for RAG in 2:112 and suppression of lymphocyte genomic instability 2:112 for lymphocyte development 5:369e377 and immune deficiency 5:370f TeBeNK + severe combined immune deficiency (TeBeNK + SCIDs) 5:370e371 N-nucleotides 2:109 P-elements 2:109 recombination activating gene (RAG) in 2:99e106 regulation of 1:71e73 of TCRgd 2:76e77 at TRA/D locus 2:93e94 at TRG locus 2:91 VEGF A 4:551 signaling 1:4e7 Velocardiofacial (VCF) 5:351 Vemurafenib 4:575 Venom immunotherapy (VIT) 5:313 Veno-occlusive disease (VOD) 5:516 Vertebrate adaptive immunity, evolutionary underpinnings of 1:466 Vertebrate cells 3:98 Vertebrate peptidoglycan recognition proteins 2:395e396 functions 2:395e396 genes, proteins, and expression 2:395 Very late antigen-1 (VLA-1) 4:318 Very late antigen-4 (VLA-4) 3:72, 3:508, 3:515e516 Very small size proteoliposomes (VSSP) IgM 2:9e10 Vesiculovacuolar organelles (VVOs) 3:75 Vg2Vd8 T cells 2:82 Vg4 + T cells 1:212 Vg5Vd1 T cells 2:78, 2:81 DETCs, elusive ligand for 2:81 Vg9Vd2 T cells 2:78e79, 2:81 human, stimulation by phosphoantigens 2:79 recognition by phosphoantigens 2:80 VH gene families 2:58 Viral anticytokine strategies 2:597e604 chemokine networks, modulation of 2:602 cytokine expression and activation, viral modulation of 2:597e599 cytokine signal transduction 2:598e599 inflammasome, inhibition of 2:598 pattern recognition receptors 2:597 future perspectives 2:602 IFN functions, modulation of 2:599e601 effector functions 2:601 interference with signal transduction induced by IFNs 2:600e601 secreted viral IFN receptors and IFN binding proteins 2:600 viral inhibition of IFN synthesis 2:599e600 immune response, viral evasion of 2:597 secreted viral cytokine receptors 2:601e602 viral cytokine binding proteins 2:602 viral cytokines 2:601 Viral CD30 2:602 Viral CKBPs (vCKBPs) 4:270e271, 4:271f, 4:274f, 4:275 Viral clearance 4:291, 4:293e295 Viral dissemination, use of DCs as vehicle for 4:216 Viral G proteinecoupled receptor homolog (vGPCR) 4:370 Viral glycoproteins 2:198 Viral hemorrhagic fevers (VHFs) 4:356 Viral IL-6 (vIL-6) 2:477 Viral infections 5:347 CD4 T cell immunity to 4:291e299 diverse functions 4:293e296 early cognate interaction 4:292e293 improved functions of memory CD4 T cells 4:296e297 vaccination to induce CD4 T cell memory 4:297e298 viral recognition initiates the CD4 T cell response 4:291 CD4 T cell immunity to. See CD4 T cell immunity to viral infection chemokines 4:270e278 Viral infections (continued) role of 4:270e271 viral chemokine homologues 4:271e272 viral chemokine receptor homologues 4:272e273 viral secreted proteins that bind chemokines 4:273e275 and class I MHC molecules 2:174 control in insects 1:460 control of 1:460 cytokines 4:225f, 4:227 dendritic cells (DCs) in. See Dendritic cells (DCs). See in viral infection human genetic defects resulting in increased susceptibility to 4:375e388 innate immune response 4:334e335 intrinsic cellular defenses in modulating 4:235e242 of mast cells 1:312e314, 1:316 MHC I antigen presentation in 4:287f MZ B cell loss during 3:222e223 natural killer (NK) cells during viral infection activation 4:243e244, 4:246e247 immune modulation infection 4:248 primary immunodeficiencies (PIDs) with selective susceptibility to 4:377e379 role of receptors binding nectin and necl proteins in controlling 2:411 sensors of 4:200e206, 4:201f, 4:201t Tcell trafficking to viral infection sites 4:318e319 Viral integration 4:366 Viral MHC homologs 2:275e276 Viral pathogenesis 4:274e275, 4:319 Viral reactivation, DRESS-associated 2:315e316 Viral restriction factors 2:501 Viral short interfering RNAs (vsiRNAs) 1:394 Viral targeting, of MHC-I and APPM Virus-specific T cells (VSTs) 4:560e562 Visceral adipose tissue (VAT) 3:339e340, 5:37e38 Visceral leishmaniasis (VL) 4:116, 4:118e119 genome-wide association studies (GWAS) on 4:12 Vitamin A (retinol) 3:475, 5:11e12, 5:120e121 deficiency 3:153 Vitamin B1 5:121 Vitamin B2 (riboflavin) 2:267, 5:121e122 precursors and derivatives 2:267 Vitamin B3 5:122, 5:374 Vitamin B6 5:122, 5:495te496t, 5:499e500 Vitamin B7 5:122 Vitamin B9 5:122e123 Vitamin B12 5:123 Vitamin C 5:123 Vitamin D 5:183 Vitamin D receptor (VDR) 3:147, 3:154e155, 3:403 Vitamin D3 4:519te520t, 5:123e124 Vitamin D3 receptor (VDR) 5:123e124 Vitamin E 5:124 Vitiligo 5:34 VL-disruptive mutations 2:156 VLR 1:468e470 VLRA + cells 1:470 effector functions of 1:471e472 VLRB + cells 1:470 effector functions of 1:471 VLRC + cells 1:470 effector functions of 1:471e472 VNTR 2:381 Voltage-gated sodium channel (VGSC), in DP thymocytes 1:245 Von Willebrand D-domain (VWD) 2:386 VpreB 1:57 VSIG4. See CR1g Vulvar intraepithelial neoplasia (VIN) 4:417e418",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": " 2:223, 2:489, 2:494, 4:23e24, 4:23f, 4:246, 5:152, 5:219e220, 5:249, 5:292 alleles 2:170 and allergy 2:170 and alloimmunity, of amphibians 1:488 antigen processing 2:167e169 and asthma 2:170 autoimmunity 2:170e171 CIITA. See Complex (MHC) II transactivator (CIITA) European rabbit 1:518 genes 2:255 genetics 2:169e170 associated with reproduction 2:170e171 of transplantation 2:171 genetics and genomic organization of 2:168e169 genome-wide duplication 2:169 genomic organization of 1:483f history of the discovery 2:167e168 HLA-A alleles 2:169e170 homologs 2:176 in humans. See Human leukocyte antigen (HLA) ligands 2:202e204 mammalian 2:307 mate choice 2:170e171 MR1 2:263e270 natural killer (NK) cells 2:171 nonclassical MHC molecules 2:178e189 paralogous regions 2:169 and pathogens 2:167e168, 2:170 peptide 2:167e168, 2:170e171 placenta 2:168e169 polymorphism 2:167e168, 2:170 proteins 4:253e255, 4:257e258 recombination 2:170 -related TCRgd ligands, murine 2:81e82 -restricted antigen recognition by T cells 2:175 restricted T cell epitopes 2:200e201 restriction 2:299 self-peptides 2:171 T cell 2:167e168, 2:170e171 temperature control of expression 1:483e484 Major histocompatibility complex (MHC) class I 2: 168, 3:384, 4:35, 4:344, 5:25 antigen presentation in viral infections 4:287f antigen processing 2:236 assembly of MHC I heavy chain with b2m 2:233e234 calnexin 2:233 deglucosylationereglucosylation cycle of folding 2:233e234 ERp57 2:234 oxidative folding of HC 2:234 biological and clinical impact 2:291 ERAP1 2:236e237 ERAP2 2:237 expression and quality control at cell surface 2:238 extraction of HC from folding cycle HC assembly with b2m 2:234 HC degradation 2:234 overview 2:280e282 peptide editing 2:236e238 peptide loading and selection in ER 2:236e237 components of PLC 2:236e237 enhancement of peptide selection by MHC I by tapasin 2:236 peptide trimming in ER 2:237 PLC structure 2:235f, 2:236 peptide selection and quality control of MHC I assembly in early secretory pathway 2:237e238 calreticulin 2:237 TAP-binding protein related 2:238 UDP-glucose:glycoprotein glucosyltransferase 2:237e238 polypeptide-related sequence A (MICA) 2:80e81 polypeptide-related sequence B (MICB) 2:80e81 supertypes and their peptide-binding specificities 2:203t thymus-leukemia (TL) molecule 1:276 transport of peptides into ER by TAP 2:234e236 binding of cofactors and formation of preloading complex 2:235 TAP function 2:234e235 TAP structure 2:234 tapasin structure 2:235e236 tumor immunoevasion targets 2:286te288t tumor targeting of 2:289e291 viral immunoevasins and their targets 2:283te285t viral targeting of 2:282e289 Major histocompatibility complex (MHC) class I, ligands 2:225e232, 2:226f origin of 2:225e228 defective ribosomal products 2:227 mechanistic mysteries 2:227e228 physiologic protein turnover 2:225e227 processing of 2:228e231 crosspresented antigens 2:230e231 exopeptidase trimming 2:229e230 nonconventional processing 2:230 proteasome 2:228e229 Major histocompatibility complex (MHC) class II 1:303, 1:331, 1:484, 2:168e169, 2:248, 3:384, 4:35, 5:378e390antigen presentation 2:249e251 antigen processing 2:243e245 immunodominance 2:245 pH 2:244e245 proteases 2:243 associated with a variable reduction in MHCI 5:381e386 carrier detection and diagnosis 5:385 clinical and pathological manifestations 5:385 defective regulation of MHCII expression 5:382 genetic heterogeneity 5:382e384 identification and incidence 5:381 immunological characteristics 5:384e385 treatment and prognosis 5:385e386 cell surface expression 2:250 chaperones in 2:241e242 DM and DO 2:241e242 invariant chain 2:241 expression 1:540 ligand selection in loading compartments 2:249e250 loading compartment (MIIC) 3:48 MHC II antigen presentation pathway in B cells 2:250e251 MHC II/peptide complexes in APC 2:248 mouse models for 5:386e387 pathways 2:248e250 and peptide complexes 2:250 recycling pathway 2:251 regulation of 2:242e243 transcription 2:243 ubiquitination 2:242e243 activation 5:480e481 activation disorders 5:495te496t, 5:500 atypical ubiquitin chains and monoubiquitination 3:59e60 canonical NF-kB signaling 3:53 deficiencies 5:395 deubiquitinases that regulate NF-kB 3:52f, 3:60 A20 3:60 expression 1:8e9 IKK complex 2:537e538 K48-linked ubiquitin chains 3:59 K63-linked ubiquitin chains 3:59 linear ubiquitin chains 3:59 -mediated immunity 5:410 mutations 5:473 noncanonical NF-kB signaling 3:52e53 proteins, N-terminal Rel homology domain (RHD) of 4:46e47 signaling pathways 3:31 leading to canonical NF-kB activation 3:54e59 TCR 3:57e58, 3:57f TNFR 3:56, 3:56f transcription factor 3:155 ubiquitin ligase 3:51, 3:55, 3:58e60 ubiquitin signaling to 3:51e64 ubiquitin system 3:52e53 ubiquitin-binding domain (UBD) 3:51 Sex differences (continued) effect on cellular immunity 5:86e94 genetic and hormonal basis for in T cell responses to vaccination in mice 5:87e88 in immunity 5:95 humoral immunity 5:97e98 in innate immunity 5:98 mechanisms of androgen suppression of Th1 responses in the periphery 5:89e91 suppression of APC function and production of IL-12 5:89e90 mechanisms of estrogens contribution to more robust cellular immune responses 5:91e92 nonobese diabetic model of T1D 5:91 in T cell development 5:88e89 T cell proliferation and Th1 cytokine production 5:90e91 IFNg transcription by increasing PPAR- and bone marrow 1:182, 1:184e186 lymphoid progenitors 1:184e185Notch ligands 1:182e184, 1:183f, 1:188 Notch signaling pathway 1:182e184, 1:183f functions in T cell progenitors 1:186e188, 1:187f Notch and human T cell development 1:188 regulation in thymus 1:184e186 and thymopoiesis in non-steady-state conditions 1:188 perspectives 1:188 receptors 1:182e184 and selection 1:257 sex differences in 5:88e89 effects of androgens and estrogens on thymopoiesis 5:88e89 na\u00efve T cells in periphery 5:88 in Treg development 5:89 thymocyte selection 1:243e247 T cell development, by common g chain cytokines 1:192e200 ab T cell lineage specification, influence of g c on 1:195e196 CD4 versus CD8 lineage choice 1:195 thymus-derived regulatory CD4 + T cells 1:195e196 CD8 + innate/memory phenotype T cells 3:384, 4:207, 4:253, 4:286, 4:292, 4:342, 4:427, 4:434, 4:460, 4:513, 5:128, 5:222, 5:254, 5:353, 5:378 activation 2:408 affinity and signaling during thymocyte selection 1:242e248 a chain 5:292 ab receptors 2:69e75 ab-expressing T cells 1:263e264 of CD8 T lymphocytes 4:286e287 CDR3 loops 2:70 and class I MHC molecules 2:174e175 complex 1:275e276, 3:287e288 -expressing cells 1:66e67 gd 2:100 general function of 2:69 and HLA-E, interaction 2:183, 2:183f IgNAR as 2:162e163 immunological synapse 2:73 ITAMs (immunoreceptor tyrosine-based activation motifs) 2:69, 2:73 MHC binding 2:70e73 MHC-restricted 2:73 and MR1, interaction between 2:264e265 peptideeMHC complexes, TCR recognition of 2:70e72 recognition, sensitivity of 2:73e74 repertoire 1:268e270, 3:384e385, 4:435, 5:222 semi-invariant 1:219 serial triggering 2:74 signaling 2:69e70, 2:73, 3:1e8, 3:3f, 3:294 antigen-mediated 3:497 inter-TCR cross talk 3:6e7 mechanistic models and correlates of 3:2 mechanosensing and piston-like/ rotational movements 3:6 outside-in transmission of conformational changes 3:4e6 overview of 3:9e10 phosphatases, kinetic segregation of 3:4e6 preexisting TCR nanoclusters 3:3e4 regulation of Th2 Differentiation 3:295 signaling partners 3:1e2 strength, in gd T cell development 1:212e213 TCR cross-linking, need for 3:3e4 TCR occupancy and kinetic models 3:2e3 specificity and cross-reactivity 2:72 structure 2:71f, 2:73 TCRa rearrangements 1:218e219 TCRgd 3:325 innate responses of 3:328e329 TCReCD3 complex assembly of 2:69e70, 2:70f composition of 2:69 TCRepeptideeMHC complex 2:71f transgenic models 5:229e230 triggering, initiation of 2:74 unusual kinetics of TCR binding 2:74 T cell receptor excision circles (TREC) 5:243 T cell receptor (TCR) loci 2:85e98 TCR genes 2:85e94 thymic cell early development 2:86f TRA/D gene 2:91e94 cis-regulatory regions in TRA locus 2:91e93 cis-regulatory regions in TRD locus 2:93 general organization 2:91 V(D)J recombination at TRA/D locus 2:93e94 TRB gene 2:86e89 cis-regulatory regions in TRB locus 2:88 general organization 2:86e88 locus rearrangement 2:88e89 TRG gene 2:89e91 cis-regulatory regions in TRG locus 2:90e91 general organization 2:89e90 V(D)J recombination at TRG locus 2:91 T cell receptor (TCR) rearrangement excision circles ( 2:544e545, 3:115, 3:121, 3:159, 3:244, 4:125, 4:129, 4:187, 4:222, 4:358e359, 4:427, 4:512e513, 5:40e41, 5:120, 5:122e123, 5:128t, 5:185e186, 5:198e200, 5:220, 5:254, 5:267, 5 4:125e126, 4:135, 4:137e138, 4:187, 4:223, 4:301, 4:408e409, 4:411, 5:194, 5:197, 5:252 adaptive and innate immunity, distinction between 2:455 and B cell activation 3:259e268 BAFF-R biological function of 3:260e261 -mediated signaling 3:261e263 BCMA biological function of 3:263 -mediated signaling 3:263 CD40 biological function of 3:263e264 -mediated signaling 3:264 cytokines in immunity 2:454e455 Fas biological function of 3:264e265 -mediated signaling 3:265 infected/damaged cells, direct effects of TNF family members on 2:458e459 antiviral effects 2:459 cytotoxic and anticytotoxic effects 2:458e459 facilitation of lysosome-mediated destruction 2:459 innate effector mechanisms, coordination of 2:459e460 local inflammation 2:459e460, 2:459f systemic effects 2:460 innate immune triggers 2:457e458 TNF family members induction 2:458 TNF induction 2:457e458 ligand family 4:319 mediation of cross talk between adaptive and innate immunity 2:461 as mediator of acute inflammation induced by bacterial toxins 2:455e456 of chronic inflammation 2:456 modulation of cellular response to innate stimuli 2:460e461 mRNA 2:548 production 4:103e104 -related apoptosis-inducing ligand (TRAIL) 1:355e356, 3:372, 4:487, 5:25e26 relative significance of the contribution of TNF family to innate immunity 2:462 signaling mechanisms 2:461e462 gene activation pathways 2:461e462 reverse signaling 2:462 triggering caspase function independently of gene activation 2:461 triggering the functions of RIPK3 and MLKL independently of geneactivation 2:461 -stimulated gene/protein 6 (TSG6) 5:276 TACI biological function of 3:263 -mediated signaling 3:263 TNF 1:305 TNF receptor-associated factors 1:94, 2:461, 2:537e538, 3:107, 3:116 TRAF3 1:264 TRAF6 3:394 TRAF-mediated pathways 3:116e120 TNF receptors (TNFR) 3:100, 3:372, 4:288 family members 3:259e268 signaling 3:56e57 superfamily signaling pathway 3:115e123 and their ligands 3:260",
            "cite_spans": [
                {
                    "start": 1,
                    "end": 75,
                    "text": "2:223, 2:489, 2:494, 4:23e24, 4:23f, 4:246, 5:152, 5:219e220, 5:249, 5:292",
                    "ref_id": null
                },
                {
                    "start": 1201,
                    "end": 1206,
                    "text": "(MHC)",
                    "ref_id": null
                },
                {
                    "start": 1218,
                    "end": 1247,
                    "text": "168, 3:384, 4:35, 4:344, 5:25",
                    "ref_id": null
                },
                {
                    "start": 2672,
                    "end": 2677,
                    "text": "(MHC)",
                    "ref_id": null
                },
                {
                    "start": 3016,
                    "end": 3021,
                    "text": "(MHC)",
                    "ref_id": null
                },
                {
                    "start": 6140,
                    "end": 6243,
                    "text": "3:384, 4:207, 4:253, 4:286, 4:292, 4:342, 4:427, 4:434, 4:460, 4:513, 5:128, 5:222, 5:254, 5:353, 5:378",
                    "ref_id": null
                },
                {
                    "start": 8420,
                    "end": 8595,
                    "text": "2:544e545, 3:115, 3:121, 3:159, 3:244, 4:125, 4:129, 4:187, 4:222, 4:358e359, 4:427, 4:512e513, 5:40e41, 5:120, 5:122e123, 5:128t, 5:185e186, 5:198e200, 5:220, 5:254, 5:267, 5",
                    "ref_id": null
                },
                {
                    "start": 8596,
                    "end": 8683,
                    "text": "4:125e126, 4:135, 4:137e138, 4:187, 4:223, 4:301, 4:408e409, 4:411, 5:194, 5:197, 5:252",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}